General Electric (GE) 10-Q23 Jul 242024 Q2 Quarterly reportFinancial data

Company Profile

COVER

COVER	6 Months Ended
COVER	Jun. 30, 2024 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-00035
Entity Registrant Name	GENERAL ELECTRIC COMPANY
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	14-0689340
Entity Address, Address Line One	1 Neumann Way
Entity Address, City or Town	Evendale
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45215
City Area Code	617
Local Phone Number	443-3000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	1,084,311,016
Amendment Flag	false
Entity Central Index Key	0000040545
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	GE
Security Exchange Name	NYSE
0.875% Notes Due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
Trading Symbol	GE 25
Security Exchange Name	NYSE
1.875% Notes Due 2027
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2027
Trading Symbol	GE 27E
Security Exchange Name	NYSE
1.500% Notes Due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2029
Trading Symbol	GE 29
Security Exchange Name	NYSE
7.5% Guaranteed Subordinated Notes Due 2035
Entity Information [Line Items]
Title of 12(b) Security	7 1/2% Guaranteed Subordinated Notes due 2035
Trading Symbol	GE /35
Security Exchange Name	NYSE
2.125% Notes Due 2037
Entity Information [Line Items]
Title of 12(b) Security	2.125% Notes due 2037
Trading Symbol	GE 37
Security Exchange Name	NYSE

STATEMENT OF EARNINGS (LOSS) (U

STATEMENT OF EARNINGS (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Insurance revenues (Note 12)	$ 871	$ 847	$ 1,750	$ 1,639
Total revenues	9,094	8,755	18,048	16,591
Costs and expenses
Selling, general and administrative expenses	924	913	1,950	1,845
Separation costs	75	163	334	327
Research and development	300	239	570	468
Interest and other financial charges	248	249	511	497
Insurance losses, annuity benefits and other costs (Note 12)	667	735	1,293	1,418
Non-operating benefit cost (income)	(204)	(249)	(421)	(488)
Total costs and expenses	7,584	7,742	15,558	14,759
Other income (loss) (Note 18)	(63)	496	944	6,600
Earnings (loss) from continuing operations before income taxes	1,447	1,509	3,434	8,432
Benefit (provision) for income taxes (Note 15)	(125)	(253)	(369)	(467)
Earnings (loss) from continuing operations	1,322	1,256	3,065	7,965
Earnings (loss) from discontinued operations, net of taxes (Note 2)	(54)	(1,218)	(232)	(447)
Net earnings (loss)	1,268	37	2,833	7,518
Less net earnings (loss) attributable to noncontrolling interests	2	4	28	(23)
Net earnings (loss) attributable to the Company	1,266	33	2,805	7,541
Preferred stock dividends	0	(58)	0	(204)
Net earnings (loss) attributable to common shareholders	1,266	(25)	2,805	7,338
Amounts attributable to common shareholders
Earnings (loss) from continuing operations	1,322	1,256	3,065	7,965
Less net earnings (loss) attributable to noncontrolling interests, continuing operations	2	2	4	6
Earnings (loss) from continuing operations attributable to the Company	1,320	1,254	3,061	7,958
Preferred stock dividends	0	(58)	0	(204)
Earnings (loss) from continuing operations attributable to common shareholders	1,320	1,195	3,061	7,755
Earnings (loss) from discontinued operations attributable to common shareholders	(54)	(1,221)	(256)	(417)
Net earnings (loss) attributable to common shareholders	$ 1,266	$ (25)	$ 2,805	$ 7,338
Earnings (loss) per share from continuing operations (Note 17)
Diluted earnings (loss) per share (in dollars per share)	$ 1.20	$ 1.09	$ 2.78	$ 7.06
Basic earnings (loss) per share (in dollars per share)	1.21	1.10	2.81	7.12
Net earnings (loss) per share (Note 17)
Diluted earnings (loss) per share (in dollars per share)	1.15	(0.02)	2.55	6.68
Basic earnings (loss) per share (in dollars per share)	$ 1.16	$ (0.02)	$ 2.58	$ 6.74
Equipment
Revenues
Sales	$ 2,175	$ 2,532	$ 4,596	$ 4,506
Costs and expenses
Cost of sales	2,302	2,626	4,767	4,744
Services
Revenues
Sales	6,047	5,375	11,702	10,446
Costs and expenses
Cost of sales	$ 3,273	$ 3,066	$ 6,554	$ 5,947

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION (UNAUDITED) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Cash, cash equivalents and restricted cash	$ 12,107	$ 15,204
Investment securities (Note 3)	3,338	5,706
Current receivables (Note 4)	8,370	8,703
Inventories, including deferred inventory costs (Note 5)	9,469	8,284
Current contract assets (Note 8)	2,719	2,875
All other current assets (Note 9)	1,210	1,244
Assets of businesses held for sale (Note 2)	137	541
Current assets	37,352	42,556
Investment securities (Note 3)	38,129	38,000
Property, plant and equipment – net (Note 6)	7,095	7,246
Goodwill (Note 7)	8,859	8,948
Other intangible assets – net (Note 7)	4,394	4,642
Contract and other deferred assets (Note 8)	4,801	4,785
All other assets (Note 9)	13,405	11,695
Deferred income taxes (Note 15)	7,338	7,502
Assets of discontinued operations (Note 2)	1,817	47,927
Total assets	123,190	173,300
Short-term borrowings (Note 10)	1,700	1,108
Accounts payable (Note 11)	7,707	7,516
Progress collections (Note 8)	6,465	6,177
Contract liabilities and deferred income (Note 8)	8,671	8,322
Sales discounts and allowances (Note 14)	3,639	3,741
All other current liabilities (Note 14)	4,506	4,860
Liabilities of businesses held for sale (Note 2)	61	378
Current liabilities	32,750	32,103
Deferred income (Note 8)	960	975
Long-term borrowings (Note 10)	17,973	19,417
Insurance liabilities and annuity benefits (Note 12)	37,215	39,624
Non-current compensation and benefits (Note 14)	7,248	7,656
All other liabilities (Note 14)	6,534	5,708
Liabilities of discontinued operations (Note 2)	1,667	39,213
Total liabilities	104,347	144,695
Common stock (1,084,311,016 and 1,088,415,995 shares outstanding at June 30, 2024 and December 31, 2023, respectively) (Note 16)	15	15
Accumulated other comprehensive income (loss) – net attributable to the Company (Note 16)	(4,035)	(6,150)
Other capital	25,282	26,962
Retained earnings	77,349	86,553
Less common stock held in treasury	(80,013)	(79,976)
Total shareholders’ equity	18,598	27,403
Noncontrolling interests	245	1,202
Total equity	18,843	28,605
Total liabilities and equity	$ 123,190	$ 173,300

STATEMENT OF FINANCIAL POSITI_2

STATEMENT OF FINANCIAL POSITION (UNAUDITED) (Parenthetical) - shares	Jun. 30, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Common stock, shares outstanding	1,084,311,016	1,088,415,995

STATEMENT OF CASH FLOWS (UNAUDI

STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	6 Months Ended
STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	Jun. 30, 2024	Jun. 30, 2023
Cash flows – operating activities
Net earnings (loss)	$ 2,833	$ 7,518
(Earnings) loss from discontinued operations activities	232	447
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities:
Depreciation and amortization of property, plant and equipment	401	394
Amortization of intangible assets (Note 7)	172	184
(Gains) losses on equity securities (Note 18)	(314)	(6,286)
Principal pension plans cost (Note 13)	(328)	(380)
Principal pension plans employer contributions	(94)	(90)
Other postretirement benefit plans (net)	(155)	(189)
Provision (benefit) for income taxes (Note 15)	369	467
Cash recovered (paid) during the year for income taxes	91	(486)
Changes in operating working capital:
Decrease (increase) in current receivables	(48)	(341)
Decrease (increase) in inventories, including deferred inventory costs	(1,201)	(667)
Decrease (increase) in current contract assets	155	63
Increase (decrease) in contract liabilities and current deferred income	386	617
Increase (decrease) in progress collections	290	52
Increase (decrease) in accounts payable	427	186
Increase (decrease) in sales discount and allowances	(102)	32
All other operating activities	(528)	42
Cash from (used for) operating activities – continuing operations	2,586	1,564
Cash from (used for) operating activities – discontinued operations	(681)	(1,338)
Cash from (used for) operating activities	1,905	226
Cash flows – investing activities
Additions to property, plant and equipment and internal-use software	(499)	(390)
Dispositions of property, plant and equipment	87	48
Proceeds from principal business dispositions	74	0
Net cash from (payments for) principal businesses purchased	0	(41)
Sales of retained ownership interests	2,610	4,304
Net (purchases) dispositions of insurance investment securities	(965)	(1,381)
All other investing activities	(3,294)	(259)
Cash from (used for) investing activities – continuing operations	(1,987)	2,281
Cash from (used for) investing activities – discontinued operations	(1,491)	(2,452)
Cash from (used for) investing activities	(3,478)	(171)
Cash flows – financing activities
Net increase (decrease) in borrowings (maturities of 90 days or less)	2	(60)
Newly issued debt (maturities longer than 90 days)	0	0
Repayments and other debt reductions (maturities longer than 90 days)	(616)	(2,526)
Dividends paid to shareholders	(394)	(350)
Redemption of preferred stock	0	(3,000)
Purchases of common stock for treasury	(2,623)	(632)
All other financing activities	636	218
Cash from (used for) financing activities – continuing operations	(2,994)	(6,349)
Cash from (used for) financing activities – discontinued operations	(98)	1,955
Cash from (used for) financing activities	(3,092)	(4,394)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash	(143)	79
Increase (decrease) in cash, cash equivalents and restricted cash	(4,808)	(4,260)
Cash, cash equivalents and restricted cash at beginning of year	19,755	19,092
Cash, cash equivalents and restricted cash at June 30	14,947	14,832
Less cash, cash equivalents and restricted cash of discontinued operations at June 30	(1,398)	(3,104)
Cash, cash equivalents and restricted cash of continuing operations at June 30	$ 13,549	$ 11,728

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 1,268	$ 37	$ 2,833	$ 7,518
Less: net earnings (loss) attributable to noncontrolling interests	2	4	28	(23)
Net earnings (loss) attributable to the Company	1,266	33	2,805	7,541
Other comprehensive income (loss)
Currency translation adjustments	2,123	95	2,087	2,481
Benefit plans	(789)	(173)	(987)	(2,492)
Investment securities and cash flow hedges	(304)	(474)	(758)	231
Long-duration insurance contracts	518	267	1,753	(1,527)
Less: other comprehensive income (loss) attributable to noncontrolling interests	(19)	(2)	(17)	(5)
Other comprehensive income (loss) attributable to the Company	1,568	(284)	2,115	(1,301)
Comprehensive income (loss)	2,817	(249)	4,931	6,212
Less: comprehensive income (loss) attributable to noncontrolling interests	(17)	3	11	(28)
Comprehensive income (loss) attributable to the Company	$ 2,834	$ (251)	$ 4,920	$ 6,240

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Millions		Total	GE Aerospace shareholders' equity balance	Accumulated other comprehensive income (loss)	Currency translation adjustments	Benefit plans	Investment securities and cash flow hedges AOCI	Long-duration insurance contracts	Other capital	Retained earnings	Common stock held in treasury	Noncontrolling Interests balance	[3]
Beginning balance at Dec. 31, 2022				$ (2,272)				$ (983)	$ 34,173	$ 83,001	$ (81,209)
Ending balance at Mar. 31, 2023				(3,289)				(2,776)	30,729	84,982	(80,762)
Beginning balance at Dec. 31, 2022				(2,272)				(983)	34,173	83,001	(81,209)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					$ 2,484	$ (2,490)	$ 231	(1,527)
Purchases											(638)
Dispositions									(1,012)		1,323
Stock-based compensation									170
Other changes	[1]								(2,906)
Net earnings (loss) attributable to the Company		$ 7,541								7,541
Dividends and other transactions with shareholders	[2]									(5,676)
Other										6
Ending balance at Jun. 30, 2023		32,393	$ 31,219	(3,573)	(3,409)	4,041	(1,696)	(2,510)	30,426	84,873	(80,524)	$ 1,174
Beginning balance at Mar. 31, 2023				(3,289)				(2,776)	30,729	84,982	(80,762)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					96	(173)	(474)	267
Purchases											(326)
Dispositions									(393)		564
Stock-based compensation									97
Other changes	[1]								(8)
Net earnings (loss) attributable to the Company		33								33
Dividends and other transactions with shareholders	[2]									(142)
Other										0
Ending balance at Jun. 30, 2023		32,393	31,219	(3,573)	(3,409)	4,041	(1,696)	(2,510)	30,426	84,873	(80,524)	1,174
Preferred stock issued		3
Common stock issued		15
Common stock issued		15
Beginning balance at Dec. 31, 2023		28,605		(6,150)				(3,354)	26,962	86,553	(79,976)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					2,109	(980)	(768)	1,753
Purchases											(2,652)
Dispositions									(1,877)		2,615
Stock-based compensation									232
Other changes	[1]								(35)
Net earnings (loss) attributable to the Company		2,805								2,805
Dividends and other transactions with shareholders	[2]									(11,987)
Other										(21)
Ending balance at Jun. 30, 2024		18,843	18,598	(4,035)	(1,514)	806	(1,727)	(1,601)	25,282	77,349	(80,013)	245
Beginning balance at Mar. 31, 2024				(5,603)				(2,119)	25,887	88,090	(78,508)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					2,144	(780)	(314)	518
Purchases											(2,335)
Dispositions									(686)		831
Stock-based compensation									118
Other changes	[1]								(36)
Net earnings (loss) attributable to the Company		1,266								1,266
Dividends and other transactions with shareholders	[2]									(11,989)
Other										(18)
Ending balance at Jun. 30, 2024		18,843	$ 18,598	$ (4,035)	$ (1,514)	$ 806	$ (1,727)	$ (1,601)	$ 25,282	$ 77,349	$ (80,013)	$ 245
Preferred stock issued		0
Common stock issued		$ 15

[1]Included a $3,000 million decrease substantially all in Other capital related to our redemption of GE Series D preferred stock in the first quarter of 2023[2]Included a $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023. Included a $11,375 million decrease in Retained earnings reflecting a distribution of all the shares of GE Vernova on April 2, 2024.[3]Included a reclassification of $1,007 million of noncontrolling interests attributable to GE Vernova to retained earnings as a result of the separation on April 2, 2024.

STATEMENT OF CHANGES IN SHARE_2

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	Apr. 02, 2024	Jan. 03, 2023
Reduction of non-controlling interest	$ 1,007
Spinoff \| GE HealthCare
Ownership interest disposed of		80.10%
Retained earnings
Spinoff transaction adjustment	$ 11,375	$ 5,300

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, contract assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, incremental losses related to our contingencies, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications. We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. On April 2, 2024, the Company completed the separation of its GE Vernova business into an independent publicly traded company, GE Vernova, Inc. (GE Vernova). See Note 2 for further information.

BUSINESSES HELD FOR SALE AND DI

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	6 Months Ended
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	Jun. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, Electric Insurance Company, domiciled in Massachusetts, into held for sale. In the second quarter of 2024, we completed the sale to Riverstone International Holdings Inc. for cash proceeds of $120 million. In the second quarter of 2024, we signed a binding agreement to sell our non-core licensing business to Dolby Laboratories, Inc. for cash proceeds of $429 million, and classified the business as held for sale. GE Aerospace will retain intellectual property related to its core aerospace and defense technologies as well as the trademark portfolio for the GE brand. We expect to complete the sale, subject to regulatory approvals and other customary closing conditions, in the second half of 2024. Closing the transaction is expected to result in a gain. ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE June 30, 2024 December 31, 2023 Non-current captive insurance investment securities $ — $ 570 Property, plant and equipment and intangible assets - net 89 17 Valuation allowance on disposal group classified as held for sale — (124) All other assets 49 77 Assets of businesses held for sale $ 137 $ 541 Insurance liabilities and annuity benefits $ — $ 376 Accounts payable and other liabilities 21 1 Borrowings 39 — Liabilities of businesses held for sale $ 61 $ 378 DISCONTINUED OPERATIONS primarily comprise our former GE Vernova and GE HealthCare businesses, our mortgage portfolio in Poland (Bank BPH) and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis. GE Vernova. On April 2, 2024, we completed the previously announced separation of GE Vernova. The separation was structured as a tax-free spin-off and was achieved through the Company's pro-rata distribution of all the outstanding shares of GE Vernova to holders of the Company's common stock. In connection with the GE Vernova separation, the historical results of GE Vernova and certain assets and liabilities included in the separation are reported in GE Aerospace consolidated financial statements as discontinued operations. In addition, the Company contributed $515 million of cash to fund GE Vernova’s future operations such that GE Vernova’s cash balance on the date of separation was $4,242 million. We have continuing involvement with GE Vernova primarily through ongoing sales of products, a transition services agreement, through which GE Aerospace and GE Vernova continue to provide certain services to each other for a period of time following the separation, a separation and distribution agreement, including performance and financial guarantees, a tax matters agreement and a trademark licensing agreement. For the three months ended June 30, 2024, we had direct and indirect sales of $69 million to GE Vernova, primarily related to engine sales and parts. We collected net cash of $477 million related to the transition services agreement and sales of engines and parts. GE HealthCare . On January 3, 2023, we completed the previously announced separation of our HealthCare business, into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The separation was structured as a tax-free spin-off and was achieved through the Company's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of the Company's common stock. In connection with the separation, the historical results of GE HealthCare and certain assets and liabilities included in the separation are reported in GE Aerospace consolidated financial statements as discontinued operations. We have continuing involvement with GE HealthCare primarily through a transition services agreement, through which GE Aerospace and GE HealthCare continue to provide certain services to each other for a period of time following the separation, a tax matters agreement and a trademark licensing agreement. For the six months ended June 30, 2024, we collected net cash of $157 million related to these activities. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. As previously reported, a settlement program was adopted and we recorded a charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH was $2,474 million and $2,669 million as of June 30, 2024 and December 31, 2023, respectively. In order to maintain appropriate regulatory capital levels, during the year ended December 31, 2023, we made the previously reported non-cash capital contributions in the form of intercompany loan forgiveness of $1,797 million; no incremental contributions from GE Aerospace were required during the six months ended June 30, 2024. For further information about the recent actions and other factors that are relevant to the estimate of total losses for borrower litigation at Bank BPH, see Note 22. Future changes or adverse developments could increase our estimate of total losses and potentially require future cash contributions to Bank BPH. The Bank BPH financing receivable portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields and estimates with respect to ongoing borrower litigation. Earnings (loss) from discontinued operations were zero in pre-tax charges for both the three and six months ended June 30, 2024, and $1,014 million and $1,189 million in pre-tax charges for the three and six months ended June 30, 2023, respectively, primarily related to the ongoing borrower litigation. At June 30, 2024, the total portfolio had no carrying value, net of a valuation allowance. RESULTS OF DISCONTINUED OPERATIONS Three months ended June 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ — $ 8,136 $ — $ — $ 8,136 Cost of equipment and services sold — — — — (6,885) — — (6,885) Other income, costs and expenses (11) 10 (2) (2) (1,373) — (1,040) (2,412) Earnings (loss) of discontinued operations before income taxes (11) 10 (2) (2) (121) — (1,040) (1,161) Benefit (provision) for income taxes (58) (2) (1) (61) (79) 6 11 (62) Earnings (loss) of discontinued operations, net of taxes (68) 8 (3) (63) (200) 6 (1,029) (1,222) Gain (loss) on disposal before income taxes — — 9 9 — — 4 4 Benefit (provision) for income taxes — — — — — — — — Gain (loss) on disposal, net of taxes — — 9 9 — — 4 4 Earnings (loss) from discontinued operations, net of taxes $ (68) $ 8 $ 6 $ (54) $ (200) $ 6 $ (1,025) $ (1,218) RESULTS OF DISCONTINUED OPERATIONS Six months ended June 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ 7,244 $ — $ — $ 7,244 $ 14,923 $ — $ — $ 14,923 Cost of equipment and services sold (6,074) — — (6,074) (12,752) — — (12,752) Other income, costs and expenses (1,299) 11 4 (1,284) (2,719) (20) (1,241) (3,980) Earnings (loss) of discontinued operations before income taxes (129) 11 4 (115) (548) (20) (1,241) (1,809) Benefit (provision) for income taxes (132) (2) 5 (129) (137) 1,485 10 1,359 Earnings (loss) of discontinued operations, net of taxes (261) 9 9 (243) (685) 1,466 (1,231) (450) Gain (loss) on disposal before income taxes — — 11 11 — — 4 4 Benefit (provision) for income taxes — — — — — — — — Gain (loss) on disposal, net of taxes — — 11 11 — — 4 4 Earnings (loss) from discontinued operations, net of taxes $ (261) $ 9 $ 20 $ (232) $ (685) $ 1,466 $ (1,227) $ (447) The tax benefit for the six months ended June 30, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS June 30, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 1,398 $ 3,762 Current receivables 12 7,324 Inventories, including deferred inventory costs — 8,245 Goodwill — 4,437 Other intangible assets - net — 1,053 Contract and other deferred assets — 8,959 Property, plant and equipment - net 48 5,306 All other assets 332 5,750 Deferred income taxes 28 3,093 Assets of discontinued operations(a)(b) $ 1,817 $ 47,927 Accounts payable $ 81 $ 8,475 Contract liabilities, progress collections & deferred income — 15,255 Long-term borrowings — 294 Non-current compensation and benefits 34 3,589 All other liabilities(a) 1,552 11,600 Liabilities of discontinued operations(b) $ 1,667 $ 39,213 (a) Included $1,742 million and $1,963 million of valuation allowances against financing receivables held for sale, of which $1,501 million and $1,712 million related to estimated borrower litigation losses, and $973 million and $957 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of June 30, 2024 and December 31, 2023, respectively. Accordingly, total estimated losses related to borrower litigation were $2,474 million and $2,669 million as of June 30, 2024 and December 31, 2023, respectively. As a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of June 30, 2024 and December 31, 2023. (b) Included $113 million and $46,233 million of assets and $288 million and $38,021 million of liabilities for GE Vernova as of June 30, 2024 and December 31, 2023, respectively.

INVESTMENT SECURITIES

INVESTMENT SECURITIES	6 Months Ended
INVESTMENT SECURITIES	Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]
INVESTMENT SECURITIES	INVESTMENT SECURITIES. The majority of our investment securities are held within our run-off insurance operations and are classified as non-current as they support the long-duration insurance liabilities and include debt securities all classified as available-for-sale, substantially all of which are investment-grade. Our remaining equity shares in GE HealthCare comprised 30.5 million shares (approximately 6.7% ownership interest) at June 30, 2024. Our senior note from AerCap, for which we have adopted the fair value option and matures in the fourth quarter of 2025, is still outstanding as of June 30, 2024. June 30, 2024 December 31, 2023 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity (GE HealthCare) $ — $ — $ — $ 2,379 $ — $ — $ — $ 4,761 Equity note (AerCap) — — — 959 — — — 944 Current investment securities $ — $ — $ — $ 3,338 $ — $ — $ — $ 5,706 Debt U.S. corporate $ 27,771 $ 618 $ (2,122) $ 26,268 $ 27,495 $ 1,034 $ (1,606) $ 26,923 Non-U.S. corporate 2,710 23 (270) 2,463 2,529 34 (209) 2,353 State and municipal 2,647 36 (220) 2,464 2,828 79 (185) 2,723 Mortgage and asset-backed 5,044 40 (220) 4,864 4,827 34 (291) 4,571 Government and agencies 1,985 1 (114) 1,873 1,213 3 (116) 1,100 Other equity 198 — — 198 331 — — 331 Non-current investment securities $ 40,356 $ 719 $ (2,946) $ 38,129 $ 39,222 $ 1,183 $ (2,406) $ 38,000 The amortized cost of debt securities excludes accrued interest of $468 million and $466 million at June 30, 2024 and December 31, 2023, respectively , which is reported in All other current assets. The estimated fair value of investment securities at June 30, 2024 decreased since December 31, 2023, primarily due to share sales of our GE HealthCare equity interest and higher market yields partially offset by new investments at Insurance and the mark-to-market effect on our equity interest in GE HealthCare. Total estimated fair value of debt securities in an unrealized loss position were $21,476 million and $18,730 million, of which $16,283 million and $17,146 million had gross unrealized losses of $(2,813) million and $(2,370) million and had been in a loss position for 12 months or more at June 30, 2024 and December 31, 2023, respectively. Gross unrealized losses of $(2,946) million at June 30, 2024 included $(2,122) million related to U.S. corporate securities, $(138) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(71) million related to Asset-backed securities. The majority of our U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology and insurance industries. The majority of our CMBS and Asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis. Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV) $ (378) $ 522 $ 62 $ 6,562 Proceeds from debt/equity securities sales and early redemptions 1,083 3,745 4,278 6,754 Gross realized gains on debt securities 9 26 17 38 Gross realized losses on debt securities (28) (25) (38) (46) Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at June 30, 2024 are as follows: Amortized cost Estimated fair value Within one year $ 1,422 $ 1,417 After one year through five years 5,249 5,269 After five years through ten years 4,911 4,917 After ten years 23,532 21,463 We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations. The majority of our equity securities are classified within Level 1 and the majority of our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $7,088 million and $6,841 million are classified within Level 3, as significant inputs to their valuation models are unobservable at June 30, 2024 and December 31, 2023, respectively. During the six months ended June 30, 2024 and 2023 there were no significant transfers into or out of Level 3, respectively. In addition to the equity securities described above, we hold $1,141 million and $974 million of equity securities without RDFV including $1,115 million and $939 million at Insurance at June 30, 2024 and December 31, 2023, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were $29 million and $26 million, and $63 million and $35 million for the three and six months ended June 30, 2024 and 2023, respectively. These are primarily limited partnership investments in private equity, infrastructure and real estate funds that are measured at net asset value per share (or equivalent) as a practical expedient to estimated fair value and are excluded from the fair value hierarchy.

CURRENT AND LONG-TERM RECEIVABL

CURRENT AND LONG-TERM RECEIVABLES	6 Months Ended
CURRENT AND LONG-TERM RECEIVABLES	Jun. 30, 2024
Receivables [Abstract]
CURRENT AND LONG-TERM RECEIVABLES	CURRENT AND LONG-TERM RECEIVABLES CURRENT RECEIVABLES June 30, 2024 December 31, 2023 Customer receivables $ 6,484 $ 6,397 Revenue sharing partners receivables(a) 1,223 1,252 Non-income based tax receivables 117 129 Supplier advances 351 401 Receivables from disposed businesses 217 121 Other sundry receivables 114 534 Allowance for credit losses(b) (135) (132) Total current receivables $ 8,370 $ 8,703 (a) Revenue sharing partners receivables are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses increased primarily due to new provisions of $10 million. Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $240 million and $434 million in the six months ended June 30, 2024 a nd 2023, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in the Commercial Engines & Services business, the Company has no continuing involvement; fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. LONG-TERM RECEIVABLES June 30, 2024 December 31, 2023 Long-term customer receivables $ 172 $ 163 Supplier advances 30 32 Sundry receivables 114 158 Allowance for credit losses (3) (4) Total long-term receivables $ 313 $ 349

INVENTORIES, INCLUDING DEFERRED

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	6 Months Ended
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	Jun. 30, 2024
Inventory Disclosure [Abstract]
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS June 30, 2024 December 31, 2023 Raw materials and work in process $ 7,263 $ 6,531 Finished goods 1,277 1,209 Deferred inventory costs(a) 929 544 Inventories, including deferred inventory costs $ 9,469 $ 8,284

PROPERTY, PLANT AND EQUIPMENT A

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	6 Months Ended
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES June 30, 2024 December 31, 2023 Original cost $ 15,439 $ 15,338 Less accumulated depreciation and amortization (9,430) (9,252) Right-of-use operating lease assets 1,086 1,160 Property, plant and equipment – net $ 7,095 $ 7,246 Operating Lease Liabilities. Our current operating lease liabilities, included in All other current liabilities All other liabilities

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	6 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	GOODWILL AND OTHER INTANGIBLE ASSETS In conjunction with the GE Vernova separation, we changed our segment reporting structure. As a result, all prior period balances for those segments were updated to reflect this change. Commercial Engines & Services Defense & Propulsion Technologies Total Balance at January 1, 2024 $ 6,472 $ 2,476 $ 8,948 Goodwill adjustments(a) (70) (19) (88) Balance at June 30, 2024 $ 6,402 $ 2,457 $ 8,859 (a) Goodwill adjustments are primarily related to foreign currency exchange. The composition of our reporting units for evaluation of goodwill impairment has changed. As a result, we allocated goodwill among new and realigned reporting units using a relative fair value approach and performed assessments for the new reporting units. We continue to monitor our Additive reporting unit, which was not impacted by the reorganization, in our Defense & Propulsion Technologies segment as the fair value of this reporting unit was not significantly in excess of its carrying value based on the results of our most recent annual impairment test, performed in the fourth quarter of 2023. If the operating results and cash flow forecasts of the Additive reporting unit deteriorate, we may be required to impair some or all of the goodwill. At June 30, 2024, our Additive reporting unit had goodwill of $241 million.

CONTRACT AND OTHER DEFERRED ASS

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS	6 Months Ended
	Jun. 30, 2024
Contractors [Abstract]
CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS	CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS Contract assets (liabilities) and other deferred assets (income), on a net basis, increased the net liability position by $474 million for the six months ended June 30, 2024, primarily due to an increase of $435 million of long-term service agreements liabilities, and a decrease in long-term service agreement assets of $261 million, offset by an increase in equipment and other service agreements of $105 million. In aggregate, the net liability for long-term service agreements increased primarily due to billings of $4,181 million and net unfavorable changes in estimated profitability of $184 million, primarily in Commercial Engines & Services, partially offset by revenues recognized of $3,721 million. Revenues recognized for contracts included in a liability position at the beginning of the year were $3,537 million and $3,145 million for the six months ended June 30, 2024 and 2023, respectively. CONTRACT ASSETS, LIABILITIES AND OTHER DEFERRED ASSETS AND INCOME June 30, 2024 December 31, 2023 Long-term service agreements $ 2,116 $ 2,377 Equipment and other service agreements 603 498 Current contract assets $ 2,719 $ 2,875 Nonrecurring engineering costs(a) $ 2,434 $ 2,444 Customer advances and other(b) 2,367 2,342 Contract and other deferred assets 4,801 4,785 Total contract and other deferred assets $ 7,521 $ 7,660 Long-term service agreement liabilities $ 8,337 $ 7,902 Current deferred income 335 420 Contract liabilities and current deferred income $ 8,671 $ 8,322 Non-current deferred income 960 975 Total contract liabilities and deferred income $ 9,631 $ 9,297 Contract assets (liabilities) and other deferred assets (income) $ (2,111) $ (1,637) (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Defense & Propulsion Technologies segment, which are amortized ratably over each unit produced. We assess the recoverability of these costs and if we determine the costs are no longer probable of recovery, the asset is impaired. (b) Included amounts due from customers within our Commercial Engines & Services segment for the sales of engines, spare parts and services, which we collect through fixed or usage-based billings from the sale of spare parts and servicing of equipment under long-term service agreements. Progress collections

ALL OTHER ASSETS

ALL OTHER ASSETS	6 Months Ended
ALL OTHER ASSETS	Jun. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
ALL OTHER ASSETS	ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method investments, Insurance cash and cash equivalents, receivables and other investments in our run-off insurance operations, pension surplus and prepaid taxes and other deferred charges. All other non-current assets increased $1,710 million in the six months ended June 30, 2024, primarily due to an increase in Insurance cash and cash equivalents of $659 million, an increase of indemnity assets of $502 million, primarily related to GE Vernova, an increase in equity method investments of $259 million and an increase in prepaid taxes and deferred charges of $170 million. Insurance cash and cash equivalents was $1,442 million and $784 million at June 30, 2024 and December 31, 2023, respectively.

BORROWINGS

BORROWINGS	6 Months Ended
BORROWINGS	Jun. 30, 2024
Debt Disclosure [Abstract]
BORROWINGS	BORROWINGS June 30, 2024 December 31, 2023 Current portion of long-term borrowings Senior notes $ 1,630 $ 1,044 Subordinated notes and other 71 27 Other short-term borrowings — 37 Total short-term borrowings $ 1,700 $ 1,108 Senior notes 16,155 17,509 Subordinated notes 1,359 1,383 Other 458 525 Total long-term borrowings $ 17,973 $ 19,417 Total borrowings $ 19,673 $ 20,525

ACCOUNTS PAYABLE

ACCOUNTS PAYABLE	6 Months Ended
ACCOUNTS PAYABLE	Jun. 30, 2024
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE	ACCOUNTS PAYABLE June 30, 2024 December 31, 2023 Trade payables $ 5,604 $ 5,290 Supply chain finance programs 1,496 1,472 Sundry payables 608 754 Accounts payable $ 7,707 $ 7,516 We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE Aerospace receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $1,799 million and $1,510 million for the six months ended June 30, 2024 and 2023, respectively.

INSURANCE LIABILITIES AND ANNUI

INSURANCE LIABILITIES AND ANNUITY BENEFITS	6 Months Ended
INSURANCE LIABILITIES AND ANNUITY BENEFITS	Jun. 30, 2024
Insurance [Abstract]
INSURANCE LIABILITIES AND ANNUITY BENEFITS	INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $871 million and $847 million, profit was $170 million and $64 million and net earnings was $134 million and $50 million for the three months ended June 30, 2024 and 2023, respectively. For the six months ended June 30, 2024 and 2023, revenues were $1,750 million and $1,639 million, profit was $370 million and $134 million and net earnings was $292 million and $104 million, respectively. These operations were primarily supported by investment securities of $37,739 million and $37,592 million, limited partnerships of $3,741 million and $3,300 million, and a diversified commercial mortgage loan portfolio substantially all collateralized by first liens on U.S. commercial real estate properties of $1,900 million and $1,947 million (net of allowance for credit losses of $65 million and $48 million), as of June 30, 2024 and December 31, 2023, respectively. As of June 30, 2024, the commercial mortgage loan portfolio had three delinquent loans, two non-accrual loans and about one-third of the portfolio was held in the office sector, which had a weighted average loan-to-value ratio of 74%, debt service coverage of 1.5, and no scheduled maturities through 2025. A summary of our insurance liabilities and annuity benefits is presented below. June 30, 2024 Long-term care Structured settlement annuities Life Other contracts Total Future policy benefit reserves $ 25,301 $ 8,700 $ 1,010 $ 365 $ 35,376 Investment contracts — 762 — 689 1,451 Other — — 118 270 388 Total $ 25,301 $ 9,463 $ 1,127 $ 1,324 $ 37,215 December 31, 2023 Future policy benefit reserves $ 26,832 $ 9,357 $ 1,117 $ 382 $ 37,689 Investment contracts — 793 — 742 1,535 Other — — 116 285 400 Total $ 26,832 $ 10,150 $ 1,233 $ 1,409 $ 39,624 The following tables summarize balances of and changes in future policy benefits reserves. June 30, 2024 June 30, 2023 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,063 $ — $ 4,803 $ 4,059 $ — $ 4,828 Beginning balance at locked-in discount rate 3,745 — 4,773 3,958 — 5,210 Effect of changes in cash flow assumptions 16 — — 1 — — Effect of actual variances from expected experience (26) — (34) 31 — (87) Adjusted beginning of year balance 3,735 — 4,739 3,991 — 5,122 Interest accrual 101 — 90 105 — 100 Net premiums collected (196) — (140) (201) — (150) Effect of foreign currency — — (91) — — 86 Ending balance at locked-in discount rate 3,640 — 4,597 3,895 — 5,159 Effect of changes in discount rate assumptions 164 — (183) 239 — (162) Balance, end of year $ 3,803 $ — $ 4,415 $ 4,134 $ — $ 4,997 Present value of expected future policy benefits Balance, beginning of year $ 30,895 $ 9,357 $ 5,921 $ 28,316 $ 8,860 $ 5,868 Beginning balance at locked-in discount rate 27,144 8,561 5,847 27,026 8,790 6,247 Effect of changes in cash flow assumptions (10) — — (14) — — Effect of actual variances from expected experience 7 (25) (51) 26 10 (44) Adjusted beginning of year balance 27,141 8,536 5,796 27,038 8,800 6,203 Interest accrual 738 222 110 727 229 119 Benefit payments (693) (328) (219) (630) (338) (287) Effect of foreign currency — — (96) — — 91 Ending balance at locked-in discount rate 27,185 8,429 5,591 27,135 8,691 6,126 Effect of changes in discount rate assumptions 1,920 271 (166) 2,887 533 (144) Balance, end of year $ 29,105 $ 8,700 $ 5,424 $ 30,022 $ 9,224 $ 5,983 Net future policy benefit reserves $ 25,301 $ 8,700 $ 1,010 $ 25,888 $ 9,224 $ 985 Less: Reinsurance recoverables, net of allowance for credit losses (155) — (31) (186) — (34) Net future policy benefit reserves, after reinsurance recoverables $ 25,146 $ 8,700 $ 979 $ 25,702 $ 9,224 $ 952 The Statement of Earnings (Loss) for the six months ended June 30, 2024 and 2023, included gross premiums or assessments of $409 million and $424 million and interest accretion of $879 million and $869 million, respectively. For the six months ended June 30, 2024 and 2023, gross premiums or assessments was substantially all related to long-term care of $242 million and $246 million and life of $156 million and $166 million while interest accretion was substantially all related to long-term care of $637 million and $621 million and structured settlement annuities of $222 million and $229 million, respectively. The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional contracts. June 30, 2024 June 30, 2023 Undiscounted Discounted(a) Undiscounted Discounted(a) Long-term Care: Gross premiums $ 7,244 $ 4,665 $ 7,807 $ 4,995 Benefit payments 62,387 29,105 64,585 30,022 Structured Settlement Annuities: Benefit payments 18,937 8,700 19,608 9,224 Life: Gross premiums 11,886 5,323 13,620 6,125 Benefit payments 10,730 5,424 11,850 5,983 (a) Duration determined using the current discount rate as of June 30, 2024 and 2023. The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits. June 30, 2024 June 30, 2023 Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Duration (years)(a) 12.1 10.7 5.4 13.1 11.1 5.3 Interest Accretion Rate 5.6% 5.4% 5.2% 5.5% 5.4% 5.1% Current Discount Rate 5.4% 5.4% 5.1% 5.1% 5.1% 5.0% (a) Duration determined using the current discount rate as of June 30, 2024 and 2023. As of June 30, 2024 and 2023, policyholders account balances totaled $1,654 million and $1,884 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the six months ended June 30, 2024 and 2023 are primarily attributed to surrenders, withdrawals, and benefit payments of $215 million and $219 million, partially offset by net additions from separate accounts and interest credited of $142 million and $134 million, respectively. Interest on policyholder account balances is generally credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both June 30, 2024 and 2023. In the third quarter, we will complete our annual review of future policy benefit reserves cash flow assumptions, except related claim expenses which remain locked-in. If the review concludes that the assumptions need to be updated, future policy benefit reserves will be adjusted retroactively to the ASU 2018-12 transition date based on the revised net premium ratio using actual historical experience, updated cash flow assumptions, and the locked-in discount rate with the effect of those changes recognized in current period earnings. Following approval of a statutory permitted accounting practice in 2018 by our primary regulator, the Kansas Insurance Department, we have since provided a total of $15,035 million of capital contributions to our run-off insurance subsidiaries, including the final contribution of $1,820 million in the first quarter of 2024. In June 2024, we signed an agreement to exit a block of our life and health insurance business via an assumption reinsurance transaction, pending regulatory approvals and other closing conditions. See Notes 3 and 9 for further information related to our run-off insurance operations.

POSTRETIREMENT BENEFIT PLANS

POSTRETIREMENT BENEFIT PLANS	6 Months Ended
POSTRETIREMENT BENEFIT PLANS	Jun. 30, 2024
Retirement Benefits [Abstract]
POSTRETIREMENT BENEFIT PLANS	POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2023 for further information. The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Service cost for benefits earned $ 17 $ 24 $ 37 $ 45 Prior service cost amortization 1 — 4 — Expected return on plan assets (390) (594) (968) (1,188) Interest cost on benefit obligations 315 472 768 946 Net actuarial gain amortization (103) (187) (257) (359) Net periodic expense (income) $ (160) $ (285) $ (416) $ (556) Less discontinued operations $ — $ (96) $ (88) $ (188) Continuing operations - net periodic expense (income) $ (160) $ (189) $ (328) $ (368) Principal retiree benefit plans income was $21 million and $36 million for the three months ended June 30, 2024 and 2023, and $57 million and $72 million for the six months ended June 30, 2024 and 2023, respectively. Principal retiree benefit plans income from continuing operations was $21 million and $43 million for the three and six months ended June 30, 2024, respectively, and $22 million and $44 million for the three and six months ended June 30, 2023, respectively. Other pension plans expense was $1 million for the three months ended June 30, 2024 and $30 million income for the three months ended June 2023, and income of $12 million and $59 million for the six months ended June 30, 2024 and 2023, respectively. Other pension plans expense from continuing operations was $1 million and zero for the three and six months ended June 30, 2024, respectively, and income of $10 million and $20 million for the three and six months ended June 30, 2023, respectively. We have a defined contribution plan for eligible U.S. employees that provides employer contributions, which were $74 million and $103 million for the three months ended June 30, 2024 and 2023, respectively, and $163 million and $180 million for the six months ended June 30, 2024 and 2023, respectively. Employer contributions from continuing operations was $74 million and $128 million for the three and six months ended June 30, 2024, respectively, and $63 million and $110 million for the three and six months ended June 30, 2023, respectively. We also have deferred incentive compensation plans and deferred salary plans for eligible employees with expenses of $12 million and $15 million for the three months ended June 30, 2024 and 2023, and $21 million and $35 million for the six months ended June 30, 2024 and 2023, respectively. Deferred compensation expense from continuing operations was $12 million and $14 million for the three and six months ended June 30, 2024, respectively, and $12 million and $29 million for the three and six months ended June 30, 2023, respectively.

SALES DISCOUNTS AND ALLOWANCES

SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES	6 Months Ended
	Jun. 30, 2024
Other Liabilities Disclosure [Abstract]
SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES	SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES. Sales discounts and allowances decreased $102 million in the six months ended June 30, 2024, primarily due to payments to airline customers outpacing accruals on engine shipments in Commercial Engines & Services. All other current liabilities and All other liabilities primarily includes employee compensation and benefits, equipment project and commercial liabilities, loss contracts, income taxes payable and uncertain tax positions, environmental, health and safety remediations, operating lease liabilities (see Note 6) and product warranties (see Note 22). All other current liabilities decreased $355 million in the six months ended June 30, 2024, primarily due to a decrease in employee compensation and benefits of $758 million, partially offset by an increase in dividends payable of $217 million and taxes payable of $87 million. All other liabilities increased $827 million in the six months ended June 30, 2024, primarily due to increases in uncertain and other income taxes and related liabilities of $585 million, Environmental, health and safety liabilities of $142 million and indemnity liabilities of $185 million, primarily related to GE Vernova.

INCOME TAXES

INCOME TAXES	6 Months Ended
INCOME TAXES	Jun. 30, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES. Our effective income tax rate was 10.7% and 5.5% for the six months ended June 30, 2024 and 2023, respectively. The tax rate for 2024 was reduced compared to the U.S. statutory rate of 21% primarily due to separation income tax benefit associated with an increase in net state deferred tax assets that are likely to be utilized after the spin of GE Vernova, U.S. business tax credit benefits, and lower tax on global activities. The low tax rate for 2023 was reduced compared to the U.S. statutory rate of 21% primarily due to gains associated with our retained and sold ownership interests, which we expect to recover without tax and U.S. business credits. This was partially offset by separation income tax costs including disallowed expenses and valuation allowances related to the separation of GE HealthCare. The OECD (Organisation for Economic Co-operation and Development) has proposed a global minimum tax of 15% of reported profits (Pillar 2) that has been agreed upon in principle by over 140 countries. During 2023, many countries took steps to incorporate Pillar 2 model rule concepts into their domestic laws. Although the model rules provide a framework for applying the minimum tax, countries may enact Pillar 2 slightly differently than the model rules and on different timelines and may adjust domestic tax incentives in response to Pillar 2. Accordingly, we still are evaluating the potential consequences of Pillar 2 on our longer-term financial position. In 2024, we expect to incur insignificant tax expenses in connection with Pillar 2. The Internal Revenue Service (IRS) is currently auditing our consolidated U.S. income tax returns for 2016-2020. The following table presents our net deferred tax assets and net deferred tax liabilities attributable to different tax jurisdictions or different tax paying components. DEFERRED INCOME TAXES June 30, 2024 December 31, 2023 Total assets $ 7,702 $ 7,891 Total liabilities (364) (389) Net deferred income tax asset (liability) $ 7,338 $ 7,502

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	6 Months Ended
SHAREHOLDERS' EQUITY	Jun. 30, 2024
Equity [Abstract]
SHAREHOLDERS' EQUITY	SHAREHOLDERS’ EQUITY ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (AOCI) Three months ended June 30 Six months ended June 30 (Dividends per share in dollars) 2024 2023 2024 2023 Beginning balance $ (3,658) $ (3,505) $ (3,623) $ (5,893) AOCI before reclasses – net of taxes of $(39), $(13), $(13) and $(18) 29 67 (6) 220 Reclasses from AOCI – net of taxes of $103, $—, $103 and $(626)(a) 2,094 27 2,094 2,262 AOCI 2,123 95 2,087 2,481 Less AOCI attributable to noncontrolling interests (22) (2) (22) (3) Currency translation adjustments AOCI $ (1,514) $ (3,409) $ (1,514) $ (3,409) Beginning balance $ 1,586 $ 4,214 $ 1,786 $ 6,531 AOCI before reclasses – net of taxes of $(12), $12, $(4) and $(1) (54) 41 (83) (43) Reclasses from AOCI – net of taxes of $(156), $(63), $(208) and $(657)(a) (736) (214) (904) (2,449) AOCI (790) (173) (987) (2,492) Less AOCI attributable to noncontrolling interests (9) — (7) (2) Benefit plans AOCI $ 806 $ 4,041 $ 806 $ 4,041 Beginning balance $ (1,412) $ (1,222) $ (959) $ (1,927) AOCI before reclasses – net of taxes of $(92), $(127), $(208) and $61 (341) (446) (806) 272 Reclasses from AOCI – net of taxes of $13, $(3), $12 and $(3) 37 (28) 48 (41) AOCI (304) (474) (758) 231 Less AOCI attributable to noncontrolling interests 12 — 12 — Investment securities and cash flow hedges AOCI $ (1,727) $ (1,696) $ (1,727) $ (1,696) Beginning balance $ (2,119) $ (2,776) $ (3,354) $ (983) AOCI before reclasses – net of taxes of $138, $71, $466 and $(406) 518 267 1,753 (1,527) AOCI 518 267 1,753 (1,527) Long-duration insurance contracts AOCI $ (1,601) $ (2,510) $ (1,601) $ (2,510) AOCI at June 30 $ (4,035) $ (3,573) $ (4,035) $ (3,573) Dividends declared per common share(b) $ 0.56 $ 0.08 $ 0.56 $ 0.16 (a) The total reclassifications from AOCI included $1,590 million, including currency translation of $2,174 million and benefit plans of $(584) million, net of taxes, in the second quarter of 2024 related to the separation of GE Vernova. The total reclassifications from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in the first quarter of 2023 related to the separation of GE HealthCare. (b) Following the separation of GE Vernova, the Board of Directors declared a dividend of $0.28 per share in April 2024, which reflects our dividend as a standalone company, that was paid in April 2024. In June 2024, the Board of Directors declared a dividend of $0.28 per share that will be paid in July 2024. Preferred stock . In September, 2023 we redeemed the remaining outstanding shares of GE preferred stock. We redeemed 3,000 million of GE Series D preferred stock in the first quarter of 2023. GE Aerospace had 2,795,444 shares outstanding as of June 30, 2023. Common stock. GE Aerospace common stock shares outstanding were 1,084,311,016 and 1,088,415,995 at June 30, 2024 and December 31, 2023, respectively. We repurchased 13.9 million shares for $2,289 million and 15.0 million shares for $2,434 million during the three and six months ended June 30, 2024, respectively. The Company's share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be purchased in the open market, in privately negotiated transactions, under accelerated share repurchase programs or under plans complying with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION	6 Months Ended
EARNINGS PER SHARE INFORMATION	Jun. 30, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE INFORMATION	EARNINGS PER SHARE INFORMATION Three months ended June 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 1,320 $ 1,320 $ 1,254 $ 1,254 Preferred stock dividends and other(a) — — (58) (58) Earnings (loss) from continuing operations attributable to common shareholders 1,320 1,320 1,195 1,195 Earnings (loss) from discontinued operations (54) (54) (1,220) (1,220) Net earnings (loss) attributable to common shareholders 1,266 1,266 (25) (25) Shares of common stock outstanding 1,089 1,089 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 10 — Total average equivalent shares 1,100 1,089 1,098 1,089 Earnings (loss) per share from continuing operations $ 1.20 $ 1.21 $ 1.09 $ 1.10 Earnings (loss) per share from discontinued operations (0.05) (0.05) (1.11) (1.12) Net earnings (loss) per share 1.15 1.16 (0.02) (0.02) Potentially dilutive securities(b) 6 28 Six months ended June 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 3,061 $ 3,061 $ 7,951 $ 7,958 Preferred stock dividends and other(a) — — (204) (204) Earnings (loss) from continuing operations attributable to common shareholders 3,061 3,061 7,747 7,754 Earnings (loss) from discontinued operations (256) (256) (417) (417) Net earnings (loss) attributable to common shareholders 2,805 2,805 7,330 7,337 Shares of common stock outstanding 1,089 1,089 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 9 — Total average equivalent shares 1,100 1,089 1,097 1,089 Earnings (loss) per share from continuing operations $ 2.78 $ 2.81 $ 7.06 $ 7.12 Earnings (loss) per share from discontinued operations (0.23) (0.23) (0.38) (0.38) Net earnings (loss) per share 2.55 2.58 6.68 6.74 Potentially dilutive securities(b) 9 33 (a) For the three and six months ended June 30, 2023, included $(30) million related to excise tax on preferred share redemptions. (b) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive. Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and historically have been included in the calculation pursuant to the two-class method. For the three and six months ended June 30, 2024, such participating securities had an insignificant effect. Therefore, effective the second quarter of 2024, the Company calculates earnings per share using the treasury stock method. For the three and six months ended June 30, 2023, application of two-class method treatment had an insignificant effect.

OTHER INCOME (LOSS)

OTHER INCOME (LOSS)	6 Months Ended
OTHER INCOME (LOSS)	Jun. 30, 2024
Other Income and Expenses [Abstract]
OTHER INCOME (LOSS)	OTHER INCOME (LOSS) Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Investment in GE HealthCare realized and unrealized gain (loss) $ (397) $ (214) $ 219 $ 5,879 Investment in and note with AerCap realized and unrealized gain (loss) 3 572 15 378 Investment in Baker Hughes realized and unrealized gain (loss) — — — 10 Gains (losses) on retained and sold ownership interests $ (394) $ 358 $ 234 $ 6,266 Other net interest and investment income (loss) 200 128 429 296 Licensing and royalty income 51 29 107 54 Equity method income 34 20 79 57 Other items 46 (39) 95 (72) Total other income (loss) $ (63) $ 496 $ 944 $ 6,600

RESTRUCTURING CHARGES AND SEPAR

RESTRUCTURING CHARGES AND SEPARATION COSTS	6 Months Ended
RESTRUCTURING CHARGES AND SEPARATION COSTS	Jun. 30, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING CHARGES AND SEPARATION COSTS	RESTRUCTURING CHARGES AND SEPARATION COSTS RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate & Other. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate & Other. Three months ended June 30 Six months ended June 30 RESTRUCTURING CHARGES 2024 2023 2024 2023 Workforce reductions $ 42 $ 32 $ 108 $ 52 Plant closures & associated costs and other asset write-downs 5 12 24 37 Acquisition/disposition net charges and other 36 3 38 5 $ 84 $ 46 $ 170 $ 94 Cost of equipment/services $ — $ 3 $ 1 $ 6 Selling, general and administrative expenses 84 43 169 87 Total restructuring charges(a) $ 84 $ 46 $ 170 $ 94 Restructuring charges and other cash expenditures(b) $ 24 $ 97 $ 99 $ 144 (a) In the second quarter of 2024, included income of $81 million, as a result of a change in estimate of the post-employment severance benefit reserve in connection with the separation of GE Vernova. (b) Primarily related to employee severance payments. The restructuring liability as of June 30, 2024 and December 31, 2023 was $292 million and $311 million, respectively. For the three and six months ended June 30, 2024 and 2023, restructuring primarily included exit activities related to the restructuring program announced in the fourth quarter of 2022 reflecting lower Corporate & Other shared-service and footprint needs as a result of the GE HealthCare spin-off and subsequent GE Vernova spin-off. SEPARATION COSTS. In November 2021, the Company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aerospace, healthcare and energy. As discussed in Note 2, we completed this plan with the spin of GE Vernova in the second quarter of 2024. Post-separation, we expect to continue to incur operational and transition costs related to ongoing separation activities. For the three and six months ended June 30, 2024, we incurred pre-tax separation expense of $75 million and $334 million, paid $407 million and $572 million in cash, respectively, primarily related to employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation and transaction costs to transition to a stand-alone public company. These costs are presented as separation costs in our Statement of Earnings (Loss). In addition, we recognized $216 million of net tax benefit for the three months ended June 30, 2024 and $251 million of net tax benefit for the six months ended June 30, 2024, respectively, including deferred tax benefits associated with state tax attributes. For the three and six months ended June 30, 2023, we incurred pre-tax separation costs of $163 million and $327 million, recognized $14 million of net tax benefit and $3 million of net tax expense, and paid $319 million and $489 million in cash, respectively, related to separation activities. The pre-tax separation costs specifically identifiable to GE HealthCare and GE Vernova are now reflected in discontinued operations. For the three and six months ended June 30, 2024, we recognized $10 million and $10 million in pre-tax income, $2 million and $2 million of net tax expense, and spent zero and $9 million in cash, respectively, related to GE HealthCare. In addition, for the three and six months ended June 30, 2024, we recognized pre-tax separation costs of $1 million and $97 million, incurred zero and $20 million of net tax benefit and spent $38 million and $121 million in cash, respectively, related to GE Vernova. For the three and six months ended June 30, 2023, we incurred $1 million and $21 million in pre-tax costs, recognized zero and $4 million of tax benefits and spent $55 million and $140 million in cash for the six months ended June 30, 2023, respectively, related to GE HealthCare. For the three and six months ended June 30, 2023, we incurred $64 million and $104 million pre-tax separation costs, recognized $20 million of net tax benefit and $18 million of net tax expense and spent $52 million and $86 million in cash, respectively, related to GE Vernova.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	6 Months Ended
FINANCIAL INSTRUMENTS	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS	FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. June 30, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,071 $ 1,977 $ 2,110 $ 2,055 Liabilities Borrowings (Note 10) 19,673 18,949 20,525 20,218 Investment contracts (Note 12) 1,451 1,507 1,535 1,616 Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments. DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, and interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices. We use cash flow hedges primarily to reduce or eliminate the effects of foreign exchange rate changes, net investment hedges to hedge investments in foreign operations as well as fair value hedges to hedge the effects of interest rate and currency changes on debt we issued. We also use derivatives not designated as hedges from an accounting standpoint (and therefore we do not apply hedge accounting to the relationship) but otherwise serve the same economic purpose as other hedging arrangements. We use economic hedges when we have exposures to currency exchange risk for which we are unable to meet the requirements for hedge accounting or when changes in the carrying amount of the hedged item are already recorded in earnings in the same period as the derivative making hedge accounting unnecessary. Even though the derivative is an effective economic hedge, there may be a net effect on earnings in each period due to differences in the timing of earnings recognition between the derivative and the hedged item. FAIR VALUE OF DERIVATIVES June 30, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 1,287 $ 15 $ 12 $ 1,613 $ 26 $ 22 Non-qualifying currency exchange contracts and other(a) 6,842 208 17 16,277 245 56 Gross derivatives $ 8,129 $ 223 $ 29 $ 17,890 $ 271 $ 78 Netting and credit adjustments $ (13) $ (13) $ (28) $ (26) Net derivatives recognized in statement of financial position $ 210 $ 16 $ 243 $ 53 (a) Gains and (losses) included in our statement of earnings (loss) are $40 million and $46 million for the three months and $62 million and $179 million for the six months ended June 30, 2024 and 2023, respectively, primarily in SG&A, driven by hedges of deferred incentive compensation. FAIR VALUE HEDGES. All the fair value hedges were terminated in 2022 due to exposure management actions. The cumulative net gains of hedging adjustments $1,101 million and $1,162 million on discontinued hedges were included primarily in long-term borrowings CASH FLOW HEDGES AND NET INVESTMENT HEDGES Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Amount of Gain (Loss) Reclassified from AOCI into Net Income Three months and six months ended June 30 Three months and six months ended June 30 2024 2023 2024 2023 2024 2023 2024 2023 Cash flow hedges(a) $ (14) $ 19 $ (21) $ 38 $ 5 $ 17 $ 12 $ 18 Net investment hedges(b) 68 (68) 150 (133) — — — — (a) Primarily currency exchange contracts, and recognized in Costs of Equipment or Services Sold in the Statement of Earnings (Loss). (b) The carrying value of foreign currency debt designated as net investment hedges was $4,588 million and $4,726 million at June 30, 2024 and December 31, 2023, respectively. COUNTERPARTY CREDIT RISK. Our exposures to counterparties (including accrued interest) was $210 million and $241 million at June 30, 2024 and December 31, 2023, respectively. Counterparties' exposures to our derivative liability (including accrued interest), was $16 million and $53 million at June 30, 2024 and December 31, 2023, respectively.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	6 Months Ended
VARIABLE INTEREST ENTITIES	Jun. 30, 2024
Variable Interest Entities [Abstract]
VARIABLE INTEREST ENTITIES	VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $129 million and $115 million and liabilities of $121 million and $140 million at June 30, 2024 and December 31, 2023, respectively, in consolidated Variable Interest Entities (VIEs). These VIEs are primarily associated with a legacy business in Corporate & Other and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

COMMITMENTS, GUARANTEES, PRODUC

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES COMMITMENTS. We had total investment commitments of $3,930 million and unfunded lending commitments, primarily for U.S. Tax Equity, of $656 million, at June 30, 2024. The commitments primarily comprise investments by our run-off insurance operations in investment securities and other assets of $3,774 million and included within these commitments are obligations to make investments in unconsolidated VIEs of $3,671 million. See Note 21 for further information. As of June 30, 2024 we have committed to provide financing assistance of $2,696 million of future customer acquisitions of aircraft equipped with our engines. GUARANTEES . Credit support and indemnification agreements - Continuing Operations. We have provided $57 million of credit support on behalf of certain customers or associated companies, predominantly joint ventures and partnerships, using arrangements such as standby letters of credit and performance guarantees. The liability for such credit support was $7 million. Following the separation of GE Vernova, we have remaining performance and bank guarantees on behalf of GE Vernova. To support GE Vernova in selling products and services globally, we often entered into contracts on behalf of GE Vernova or issued parent company guarantees or trade finance instruments supporting the performance of what were subsidiary legal entities transacting directly with customers, in addition to providing similar credit support for non-customer related activities of GE Vernova (collectively, "GE Aerospace credit support"). Under the Separation and Distribution Agreement (SDA), GE Vernova is obligated to use reasonable best efforts to replace us as the guarantor on or terminate all such credit support instruments. Until such termination or replacement, in the event of non-fulfillment of contractual obligations by the relevant obligor(s), we could be obligated to make payments under the applicable instruments. Under the SDA, GE Vernova is obligated to reimburse and indemnify us for any such payments. Beginning in 2025, GE Vernova will pay us a quarterly fee based on amounts related to the GE Aerospace credit support. We have recorded a reserve of $169 million for our stand ready to perform obligation. Our maximum aggregate exposure under the GE Aerospace credit support cannot be reasonably estimated given the breadth of the portfolio across each of the GE Vernova businesses except for certain financial guarantees and trade finance instruments with a maximum exposure of approximately $1,426 million, which are not expected to exceed a year beyond separation. The underlying obligations are predominantly customer contracts that GE Vernova performs in the normal course of its business. We have no known instances historically where payments or performance were required by us under parent company guarantees relating to GE Vernova customer contracts. In connection with the spin-off of GE Vernova, under terms of the SDA, Transition Service Agreement (TSA) and Tax Matters Agreement (TMA), we have an obligation to indemnify GE Vernova for certain of its severance costs, environmental matters and tax matters of $168 million, of which $122 million is reserved. We also have remaining obligations under the TMA with GE Healthcare to indemnify them for certain tax costs and other indemnifications of $32 million which are fully reserved. In addition, we have $148 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $62 million. Credit support and indemnification agreements- Discontinued Operations . Following the separation of GE Vernova, we also have performance obligations related to GE Vernova's supply chain finance program and an environmental matter with a maximum aggregate exposure of $1,416 million. Also, under the SDA, TSA, and TMA agreements we have obligations to indemnify GE Vernova for certain of its technology costs, separation for certain facilities, environmental matters and tax matters of $93 million costs, which are fully reserved. GE Aerospace also has obligations under the TSA and TMA to indemnify GE HealthCare for certain technology and tax costs of $64 million which are fully reserved. We also have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $510 million with related reserves of $63 million. PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $635 million at June 30, 2024 and $639 million at December 31, 2023. LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2023 and Note 23 to the consolidated financial statements in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2024; refer to those discussions for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated. Shareholder and related lawsuits. Since November 2017, several putative shareholder class actions under the federal securities laws were filed against GE and certain affiliated individuals and consolidated into a single action currently pending in the U.S. District Court for the Southern District of New York (the Hachem case, also referred to as the Sjunde AP-Fonden case). The complaint against defendants GE and current and former GE executive officers alleged violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 related to insurance reserves and accounting for long-term service agreements and seeks damages on behalf of shareholders who acquired GE stock between February 27, 2013 and January 23, 2018. GE filed a motion to dismiss in December 2019. In January 2021, the court granted the motion to dismiss as to the majority of the claims. Specifically, the court dismissed all claims related to insurance reserves, as well as all claims related to accounting for long-term service agreements, with the exception of certain claims about historic disclosures related to factoring in the Power business that survive as to GE and its former CFO Jeffrey S. Bornstein. All other individual defendants have been dismissed from the case. In April 2022, the court granted the plaintiffs' motion for class certification for shareholders who acquired stock between February 26, 2016 and January 23, 2018. In September 2022, GE filed a motion for summary judgment on the plaintiffs' remaining claims, which the court denied in September 2023, except as to claims arising from disclosures made between November 2017 and January 2018. In April 2024, the court scheduled a trial date for November 2024. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. For a number of years, we have observed an increase in the total number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods. As previously reported, GE and Bank BPH approved the adoption of a settlement program and recorded an additional charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH was $2,474 million and $2,669 million as of June 30, 2024 and December 31, 2023, respectively. The estimate accounts for the costs of payments to borrowers who we estimate will participate in the settlement program, as well as estimates for the results of litigation with other borrowers, which in either case can exceed the value of the current loan balance, and represents our best estimate of the total losses we expect to incur over time. However, there are a number of factors that could affect the estimate in the future; refer to the disclosure about Bank BPH in our Annual Report on Form 10-K for the year ended December 31, 2023. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS . Our operations involve or have involved the use, disposal and cleanup of substances regulated under environmental protection laws, including activities for a variety of matters related to GE businesses that have been discontinued or exited. We record reserves for obligations for ongoing and future environmental remediation activities, such as the Housatonic River cleanup, and for additional liabilities we expect to incur in connection with previously remediated sites, such as natural resource damages for the Hudson River where GE completed dredging in 2019. Additionally, like many other industrial companies, we and our subsidiaries are defendants in various lawsuits related to alleged exposure by workers and others to asbestos or other hazardous materials. Liabilities for environmental remediation and worker exposure claims exclude possible insurance recoveries. It is reasonably possible that our exposure will exceed amounts accrued. However, due to uncertainties about the status of laws, regulations, technology and information related to individual sites and lawsuits, such amounts are not reasonably estimable. Total reserves related to environmental remediation and worker exposure claims were $1,897 million and $1,819 million at June 30, 2024 and December 31, 2023, respectively.

SEGMENT INFORMATION

SEGMENT INFORMATION	6 Months Ended
SEGMENT INFORMATION	Jun. 30, 2024
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION. On April 2, 2024, and in conjunction with the GE Vernova separation, we implemented an organizational change to align our reportable segments more closely with our business structure. In connection with our segment reporting change, we have recast previously reported amounts across all reportable segments to conform to current segment presentation. We have two reportable segments and three operating segments. Operating segments are aggregated into a reportable segment if the operating segments have similar quantitative economic characteristics and if the operating segments are similar in the following qualitative characteristics: (i) nature of products and services; (ii) nature of production processes; (iii) type or class of customer for their products and services; (iv) methods used to distribute the products or provide services; and (v) if applicable, the nature of the regulatory environment. We have aggregated Defense & Systems and Propulsion & Additive Technology into one reportable segment, Defense & Propulsion Technologies, based on similarity in economic characteristics, other qualitative factors and the objectives and principals of ASC 280, Segment Reporting . This is consistent with how our chief operating decision maker (CODM) allocates resources and makes decisions. Refer to our Annual Report on Form 10-K for the year ended December 31, 2023, for further information regarding our determination of segment profit for continuing operations, and for our allocations of corporate costs to our segments. SUMMARY OF REPORTABLE SEGMENTS Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Commercial Engines & Services $ 6,132 $ 5,737 $ 12,228 $ 10,969 Defense & Propulsion Technologies 2,401 2,375 4,713 4,341 Total segment revenues 8,533 8,113 16,941 15,310 Corporate & Other 561 642 1,108 1,281 Total revenues $ 9,094 $ 8,755 $ 18,048 $ 16,591 Commercial Engines & Services $ 1,679 $ 1,389 $ 3,098 $ 2,603 Defense & Propulsion Technologies 344 201 600 402 Total segment profit (loss) 2,023 1,590 3,698 3,006 Corporate & Other (534) (84) (179) 5,429 Interest and other financial charges (248) (249) (511) (497) Non-operating benefit income (cost) 204 249 421 488 Benefit (provision) for income taxes (125) (253) (369) (467) Preferred stock dividends — (58) — (204) Earnings (loss) from continuing operations attributable to common shareholders 1,320 1,195 3,061 7,755 Earnings (loss) from discontinued operations attributable to common shareholders (54) (1,221) (256) (417) Net earnings (loss) attributable to common shareholders $ 1,266 $ (25) $ 2,805 $ 7,338 EQUIPMENT & SERVICES REVENUES Three months ended June 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 1,427 $ 4,705 $ 6,132 $ 1,607 $ 4,130 $ 5,737 Defense & Propulsion Technologies 1,071 1,329 2,401 1,137 1,238 2,375 Total segment revenues $ 2,498 $ 6,034 $ 8,533 $ 2,744 $ 5,368 $ 8,113 Six months ended June 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 3,133 $ 9,095 $ 12,228 $ 2,906 $ 8,063 $ 10,969 Defense & Propulsion Technologies 2,080 2,633 4,713 1,994 2,347 4,341 Total segment revenues $ 5,213 $ 11,728 $ 16,941 $ 4,900 $ 10,410 $ 15,310 REMAINING PERFORMANCE OBLIGATION.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
FINANCIAL STATEMENT PRESENTATION	Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, contract assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, incremental losses related to our contingencies, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.
RECLASSIFICATIONS	We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. On April 2, 2024, the Company completed the separation of its GE Vernova business into an independent publicly traded company, GE Vernova, Inc. (GE Vernova).

BUSINESSES HELD FOR SALE AND _2

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS (Tables)	6 Months Ended
	Jun. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Financial Information for Assets and Liabilities of Businesses Held for Sale	ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE June 30, 2024 December 31, 2023 Non-current captive insurance investment securities $ — $ 570 Property, plant and equipment and intangible assets - net 89 17 Valuation allowance on disposal group classified as held for sale — (124) All other assets 49 77 Assets of businesses held for sale $ 137 $ 541 Insurance liabilities and annuity benefits $ — $ 376 Accounts payable and other liabilities 21 1 Borrowings 39 — Liabilities of businesses held for sale $ 61 $ 378
Schedule of Financial Information for Discontinued Operations	RESULTS OF DISCONTINUED OPERATIONS Three months ended June 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ — $ 8,136 $ — $ — $ 8,136 Cost of equipment and services sold — — — — (6,885) — — (6,885) Other income, costs and expenses (11) 10 (2) (2) (1,373) — (1,040) (2,412) Earnings (loss) of discontinued operations before income taxes (11) 10 (2) (2) (121) — (1,040) (1,161) Benefit (provision) for income taxes (58) (2) (1) (61) (79) 6 11 (62) Earnings (loss) of discontinued operations, net of taxes (68) 8 (3) (63) (200) 6 (1,029) (1,222) Gain (loss) on disposal before income taxes — — 9 9 — — 4 4 Benefit (provision) for income taxes — — — — — — — — Gain (loss) on disposal, net of taxes — — 9 9 — — 4 4 Earnings (loss) from discontinued operations, net of taxes $ (68) $ 8 $ 6 $ (54) $ (200) $ 6 $ (1,025) $ (1,218) RESULTS OF DISCONTINUED OPERATIONS Six months ended June 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ 7,244 $ — $ — $ 7,244 $ 14,923 $ — $ — $ 14,923 Cost of equipment and services sold (6,074) — — (6,074) (12,752) — — (12,752) Other income, costs and expenses (1,299) 11 4 (1,284) (2,719) (20) (1,241) (3,980) Earnings (loss) of discontinued operations before income taxes (129) 11 4 (115) (548) (20) (1,241) (1,809) Benefit (provision) for income taxes (132) (2) 5 (129) (137) 1,485 10 1,359 Earnings (loss) of discontinued operations, net of taxes (261) 9 9 (243) (685) 1,466 (1,231) (450) Gain (loss) on disposal before income taxes — — 11 11 — — 4 4 Benefit (provision) for income taxes — — — — — — — — Gain (loss) on disposal, net of taxes — — 11 11 — — 4 4 Earnings (loss) from discontinued operations, net of taxes $ (261) $ 9 $ 20 $ (232) $ (685) $ 1,466 $ (1,227) $ (447) The tax benefit for the six months ended June 30, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS June 30, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 1,398 $ 3,762 Current receivables 12 7,324 Inventories, including deferred inventory costs — 8,245 Goodwill — 4,437 Other intangible assets - net — 1,053 Contract and other deferred assets — 8,959 Property, plant and equipment - net 48 5,306 All other assets 332 5,750 Deferred income taxes 28 3,093 Assets of discontinued operations(a)(b) $ 1,817 $ 47,927 Accounts payable $ 81 $ 8,475 Contract liabilities, progress collections & deferred income — 15,255 Long-term borrowings — 294 Non-current compensation and benefits 34 3,589 All other liabilities(a) 1,552 11,600 Liabilities of discontinued operations(b) $ 1,667 $ 39,213 (a) Included $1,742 million and $1,963 million of valuation allowances against financing receivables held for sale, of which $1,501 million and $1,712 million related to estimated borrower litigation losses, and $973 million and $957 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of June 30, 2024 and December 31, 2023, respectively. Accordingly, total estimated losses related to borrower litigation were $2,474 million and $2,669 million as of June 30, 2024 and December 31, 2023, respectively. As a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of June 30, 2024 and December 31, 2023. (b) Included $113 million and $46,233 million of assets and $288 million and $38,021 million of liabilities for GE Vernova as of June 30, 2024 and December 31, 2023, respectively.

INVESTMENT SECURITIES (Tables)

INVESTMENT SECURITIES (Tables)	6 Months Ended
INVESTMENT SECURITIES (Tables)	Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Investment Securities	June 30, 2024 December 31, 2023 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity (GE HealthCare) $ — $ — $ — $ 2,379 $ — $ — $ — $ 4,761 Equity note (AerCap) — — — 959 — — — 944 Current investment securities $ — $ — $ — $ 3,338 $ — $ — $ — $ 5,706 Debt U.S. corporate $ 27,771 $ 618 $ (2,122) $ 26,268 $ 27,495 $ 1,034 $ (1,606) $ 26,923 Non-U.S. corporate 2,710 23 (270) 2,463 2,529 34 (209) 2,353 State and municipal 2,647 36 (220) 2,464 2,828 79 (185) 2,723 Mortgage and asset-backed 5,044 40 (220) 4,864 4,827 34 (291) 4,571 Government and agencies 1,985 1 (114) 1,873 1,213 3 (116) 1,100 Other equity 198 — — 198 331 — — 331 Non-current investment securities $ 40,356 $ 719 $ (2,946) $ 38,129 $ 39,222 $ 1,183 $ (2,406) $ 38,000
Realized and Unrealized Gain (Loss) on Securities	Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV) $ (378) $ 522 $ 62 $ 6,562 Proceeds from debt/equity securities sales and early redemptions 1,083 3,745 4,278 6,754 Gross realized gains on debt securities 9 26 17 38 Gross realized losses on debt securities (28) (25) (38) (46)
Contractual Maturities of Debt Securities (Excluding Mortgage and Asset-Backed Securities)	Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at June 30, 2024 are as follows: Amortized cost Estimated fair value Within one year $ 1,422 $ 1,417 After one year through five years 5,249 5,269 After five years through ten years 4,911 4,917 After ten years 23,532 21,463

CURRENT AND LONG-TERM RECEIVA_2

CURRENT AND LONG-TERM RECEIVABLES (Tables)	6 Months Ended
CURRENT AND LONG-TERM RECEIVABLES (Tables)	Jun. 30, 2024
Receivables [Abstract]
Schedule of Receivables and Allowance for Credit Losses	CURRENT RECEIVABLES June 30, 2024 December 31, 2023 Customer receivables $ 6,484 $ 6,397 Revenue sharing partners receivables(a) 1,223 1,252 Non-income based tax receivables 117 129 Supplier advances 351 401 Receivables from disposed businesses 217 121 Other sundry receivables 114 534 Allowance for credit losses(b) (135) (132) Total current receivables $ 8,370 $ 8,703 (a) Revenue sharing partners receivables are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses increased primarily due to new provisions of $10 million. LONG-TERM RECEIVABLES June 30, 2024 December 31, 2023 Long-term customer receivables $ 172 $ 163 Supplier advances 30 32 Sundry receivables 114 158 Allowance for credit losses (3) (4) Total long-term receivables $ 313 $ 349

INVENTORIES, INCLUDING DEFERR_2

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	6 Months Ended
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	Jun. 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	June 30, 2024 December 31, 2023 Raw materials and work in process $ 7,263 $ 6,531 Finished goods 1,277 1,209 Deferred inventory costs(a) 929 544 Inventories, including deferred inventory costs $ 9,469 $ 8,284

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	6 Months Ended
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	June 30, 2024 December 31, 2023 Original cost $ 15,439 $ 15,338 Less accumulated depreciation and amortization (9,430) (9,252) Right-of-use operating lease assets 1,086 1,160 Property, plant and equipment – net $ 7,095 $ 7,246

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	6 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill Balances	Commercial Engines & Services Defense & Propulsion Technologies Total Balance at January 1, 2024 $ 6,472 $ 2,476 $ 8,948 Goodwill adjustments(a) (70) (19) (88) Balance at June 30, 2024 $ 6,402 $ 2,457 $ 8,859 (a) Goodwill adjustments are primarily related to foreign currency exchange.

CONTRACT AND OTHER DEFERRED A_2

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS (Tables)	6 Months Ended
	Jun. 30, 2024
Contractors [Abstract]
Schedule of Contract Assets, Liabilities and Other Deferred Assets and Income	CONTRACT ASSETS, LIABILITIES AND OTHER DEFERRED ASSETS AND INCOME June 30, 2024 December 31, 2023 Long-term service agreements $ 2,116 $ 2,377 Equipment and other service agreements 603 498 Current contract assets $ 2,719 $ 2,875 Nonrecurring engineering costs(a) $ 2,434 $ 2,444 Customer advances and other(b) 2,367 2,342 Contract and other deferred assets 4,801 4,785 Total contract and other deferred assets $ 7,521 $ 7,660 Long-term service agreement liabilities $ 8,337 $ 7,902 Current deferred income 335 420 Contract liabilities and current deferred income $ 8,671 $ 8,322 Non-current deferred income 960 975 Total contract liabilities and deferred income $ 9,631 $ 9,297 Contract assets (liabilities) and other deferred assets (income) $ (2,111) $ (1,637) (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Defense & Propulsion Technologies segment, which are amortized ratably over each unit produced. We assess the recoverability of these costs and if we determine the costs are no longer probable of recovery, the asset is impaired. (b) Included amounts due from customers within our Commercial Engines & Services segment for the sales of engines, spare parts and services, which we collect through fixed or usage-based billings from the sale of spare parts and servicing of equipment under long-term service agreements.

BORROWINGS (Tables)

BORROWINGS (Tables)	6 Months Ended
BORROWINGS (Tables)	Jun. 30, 2024
Debt Disclosure [Abstract]
Schedule of Borrowings	June 30, 2024 December 31, 2023 Current portion of long-term borrowings Senior notes $ 1,630 $ 1,044 Subordinated notes and other 71 27 Other short-term borrowings — 37 Total short-term borrowings $ 1,700 $ 1,108 Senior notes 16,155 17,509 Subordinated notes 1,359 1,383 Other 458 525 Total long-term borrowings $ 17,973 $ 19,417 Total borrowings $ 19,673 $ 20,525

ACCOUNTS PAYABLE (Tables)

ACCOUNTS PAYABLE (Tables)	6 Months Ended
ACCOUNTS PAYABLE (Tables)	Jun. 30, 2024
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accruals	June 30, 2024 December 31, 2023 Trade payables $ 5,604 $ 5,290 Supply chain finance programs 1,496 1,472 Sundry payables 608 754 Accounts payable $ 7,707 $ 7,516

INSURANCE LIABILITIES AND ANN_2

INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	6 Months Ended
INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	Jun. 30, 2024
Insurance [Abstract]
Schedule of Insurance and Investment Contract Liabilities	A summary of our insurance liabilities and annuity benefits is presented below. June 30, 2024 Long-term care Structured settlement annuities Life Other contracts Total Future policy benefit reserves $ 25,301 $ 8,700 $ 1,010 $ 365 $ 35,376 Investment contracts — 762 — 689 1,451 Other — — 118 270 388 Total $ 25,301 $ 9,463 $ 1,127 $ 1,324 $ 37,215 December 31, 2023 Future policy benefit reserves $ 26,832 $ 9,357 $ 1,117 $ 382 $ 37,689 Investment contracts — 793 — 742 1,535 Other — — 116 285 400 Total $ 26,832 $ 10,150 $ 1,233 $ 1,409 $ 39,624
Summary of Future Policy Benefits	The following tables summarize balances of and changes in future policy benefits reserves. June 30, 2024 June 30, 2023 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,063 $ — $ 4,803 $ 4,059 $ — $ 4,828 Beginning balance at locked-in discount rate 3,745 — 4,773 3,958 — 5,210 Effect of changes in cash flow assumptions 16 — — 1 — — Effect of actual variances from expected experience (26) — (34) 31 — (87) Adjusted beginning of year balance 3,735 — 4,739 3,991 — 5,122 Interest accrual 101 — 90 105 — 100 Net premiums collected (196) — (140) (201) — (150) Effect of foreign currency — — (91) — — 86 Ending balance at locked-in discount rate 3,640 — 4,597 3,895 — 5,159 Effect of changes in discount rate assumptions 164 — (183) 239 — (162) Balance, end of year $ 3,803 $ — $ 4,415 $ 4,134 $ — $ 4,997 Present value of expected future policy benefits Balance, beginning of year $ 30,895 $ 9,357 $ 5,921 $ 28,316 $ 8,860 $ 5,868 Beginning balance at locked-in discount rate 27,144 8,561 5,847 27,026 8,790 6,247 Effect of changes in cash flow assumptions (10) — — (14) — — Effect of actual variances from expected experience 7 (25) (51) 26 10 (44) Adjusted beginning of year balance 27,141 8,536 5,796 27,038 8,800 6,203 Interest accrual 738 222 110 727 229 119 Benefit payments (693) (328) (219) (630) (338) (287) Effect of foreign currency — — (96) — — 91 Ending balance at locked-in discount rate 27,185 8,429 5,591 27,135 8,691 6,126 Effect of changes in discount rate assumptions 1,920 271 (166) 2,887 533 (144) Balance, end of year $ 29,105 $ 8,700 $ 5,424 $ 30,022 $ 9,224 $ 5,983 Net future policy benefit reserves $ 25,301 $ 8,700 $ 1,010 $ 25,888 $ 9,224 $ 985 Less: Reinsurance recoverables, net of allowance for credit losses (155) — (31) (186) — (34) Net future policy benefit reserves, after reinsurance recoverables $ 25,146 $ 8,700 $ 979 $ 25,702 $ 9,224 $ 952 The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional contracts. June 30, 2024 June 30, 2023 Undiscounted Discounted(a) Undiscounted Discounted(a) Long-term Care: Gross premiums $ 7,244 $ 4,665 $ 7,807 $ 4,995 Benefit payments 62,387 29,105 64,585 30,022 Structured Settlement Annuities: Benefit payments 18,937 8,700 19,608 9,224 Life: Gross premiums 11,886 5,323 13,620 6,125 Benefit payments 10,730 5,424 11,850 5,983 (a) Duration determined using the current discount rate as of June 30, 2024 and 2023. The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits. June 30, 2024 June 30, 2023 Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Duration (years)(a) 12.1 10.7 5.4 13.1 11.1 5.3 Interest Accretion Rate 5.6% 5.4% 5.2% 5.5% 5.4% 5.1% Current Discount Rate 5.4% 5.4% 5.1% 5.1% 5.1% 5.0%

POSTRETIREMENT BENEFIT PLANS (T

POSTRETIREMENT BENEFIT PLANS (Tables)	6 Months Ended
POSTRETIREMENT BENEFIT PLANS (Tables)	Jun. 30, 2024
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs	The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Service cost for benefits earned $ 17 $ 24 $ 37 $ 45 Prior service cost amortization 1 — 4 — Expected return on plan assets (390) (594) (968) (1,188) Interest cost on benefit obligations 315 472 768 946 Net actuarial gain amortization (103) (187) (257) (359) Net periodic expense (income) $ (160) $ (285) $ (416) $ (556) Less discontinued operations $ — $ (96) $ (88) $ (188) Continuing operations - net periodic expense (income) $ (160) $ (189) $ (328) $ (368)

INCOME TAXES (Tables)

INCOME TAXES (Tables)	6 Months Ended
INCOME TAXES (Tables)	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Schedule of Deferred Income Taxes	The following table presents our net deferred tax assets and net deferred tax liabilities attributable to different tax jurisdictions or different tax paying components. DEFERRED INCOME TAXES June 30, 2024 December 31, 2023 Total assets $ 7,702 $ 7,891 Total liabilities (364) (389) Net deferred income tax asset (liability) $ 7,338 $ 7,502

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	6 Months Ended
SHAREHOLDERS' EQUITY (Tables)	Jun. 30, 2024
Equity [Abstract]
Schedule of Shareholders' Equity	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (AOCI) Three months ended June 30 Six months ended June 30 (Dividends per share in dollars) 2024 2023 2024 2023 Beginning balance $ (3,658) $ (3,505) $ (3,623) $ (5,893) AOCI before reclasses – net of taxes of $(39), $(13), $(13) and $(18) 29 67 (6) 220 Reclasses from AOCI – net of taxes of $103, $—, $103 and $(626)(a) 2,094 27 2,094 2,262 AOCI 2,123 95 2,087 2,481 Less AOCI attributable to noncontrolling interests (22) (2) (22) (3) Currency translation adjustments AOCI $ (1,514) $ (3,409) $ (1,514) $ (3,409) Beginning balance $ 1,586 $ 4,214 $ 1,786 $ 6,531 AOCI before reclasses – net of taxes of $(12), $12, $(4) and $(1) (54) 41 (83) (43) Reclasses from AOCI – net of taxes of $(156), $(63), $(208) and $(657)(a) (736) (214) (904) (2,449) AOCI (790) (173) (987) (2,492) Less AOCI attributable to noncontrolling interests (9) — (7) (2) Benefit plans AOCI $ 806 $ 4,041 $ 806 $ 4,041 Beginning balance $ (1,412) $ (1,222) $ (959) $ (1,927) AOCI before reclasses – net of taxes of $(92), $(127), $(208) and $61 (341) (446) (806) 272 Reclasses from AOCI – net of taxes of $13, $(3), $12 and $(3) 37 (28) 48 (41) AOCI (304) (474) (758) 231 Less AOCI attributable to noncontrolling interests 12 — 12 — Investment securities and cash flow hedges AOCI $ (1,727) $ (1,696) $ (1,727) $ (1,696) Beginning balance $ (2,119) $ (2,776) $ (3,354) $ (983) AOCI before reclasses – net of taxes of $138, $71, $466 and $(406) 518 267 1,753 (1,527) AOCI 518 267 1,753 (1,527) Long-duration insurance contracts AOCI $ (1,601) $ (2,510) $ (1,601) $ (2,510) AOCI at June 30 $ (4,035) $ (3,573) $ (4,035) $ (3,573) Dividends declared per common share(b) $ 0.56 $ 0.08 $ 0.56 $ 0.16 (a) The total reclassifications from AOCI included $1,590 million, including currency translation of $2,174 million and benefit plans of $(584) million, net of taxes, in the second quarter of 2024 related to the separation of GE Vernova. The total reclassifications from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in the first quarter of 2023 related to the separation of GE HealthCare. (b) Following the separation of GE Vernova, the Board of Directors declared a dividend of $0.28 per share in April 2024, which reflects our dividend as a standalone company, that was paid in April 2024. In June 2024, the Board of Directors declared a dividend of $0.28 per share that will be paid in July 2024.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION (Tables)	6 Months Ended
EARNINGS PER SHARE INFORMATION (Tables)	Jun. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Three months ended June 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 1,320 $ 1,320 $ 1,254 $ 1,254 Preferred stock dividends and other(a) — — (58) (58) Earnings (loss) from continuing operations attributable to common shareholders 1,320 1,320 1,195 1,195 Earnings (loss) from discontinued operations (54) (54) (1,220) (1,220) Net earnings (loss) attributable to common shareholders 1,266 1,266 (25) (25) Shares of common stock outstanding 1,089 1,089 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 10 — Total average equivalent shares 1,100 1,089 1,098 1,089 Earnings (loss) per share from continuing operations $ 1.20 $ 1.21 $ 1.09 $ 1.10 Earnings (loss) per share from discontinued operations (0.05) (0.05) (1.11) (1.12) Net earnings (loss) per share 1.15 1.16 (0.02) (0.02) Potentially dilutive securities(b) 6 28 Six months ended June 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 3,061 $ 3,061 $ 7,951 $ 7,958 Preferred stock dividends and other(a) — — (204) (204) Earnings (loss) from continuing operations attributable to common shareholders 3,061 3,061 7,747 7,754 Earnings (loss) from discontinued operations (256) (256) (417) (417) Net earnings (loss) attributable to common shareholders 2,805 2,805 7,330 7,337 Shares of common stock outstanding 1,089 1,089 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 9 — Total average equivalent shares 1,100 1,089 1,097 1,089 Earnings (loss) per share from continuing operations $ 2.78 $ 2.81 $ 7.06 $ 7.12 Earnings (loss) per share from discontinued operations (0.23) (0.23) (0.38) (0.38) Net earnings (loss) per share 2.55 2.58 6.68 6.74 Potentially dilutive securities(b) 9 33 (a) For the three and six months ended June 30, 2023, included $(30) million related to excise tax on preferred share redemptions. (b) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.

OTHER INCOME (LOSS) (Tables)

OTHER INCOME (LOSS) (Tables)	6 Months Ended
OTHER INCOME (LOSS) (Tables)	Jun. 30, 2024
Other Income and Expenses [Abstract]
Schedule of Other Income (Loss)	Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Investment in GE HealthCare realized and unrealized gain (loss) $ (397) $ (214) $ 219 $ 5,879 Investment in and note with AerCap realized and unrealized gain (loss) 3 572 15 378 Investment in Baker Hughes realized and unrealized gain (loss) — — — 10 Gains (losses) on retained and sold ownership interests $ (394) $ 358 $ 234 $ 6,266 Other net interest and investment income (loss) 200 128 429 296 Licensing and royalty income 51 29 107 54 Equity method income 34 20 79 57 Other items 46 (39) 95 (72) Total other income (loss) $ (63) $ 496 $ 944 $ 6,600

RESTRUCTURING CHARGES AND SEP_2

RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	6 Months Ended
RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	Jun. 30, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	This table is inclusive of all restructuring charges in our segments and at Corporate & Other. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate & Other. Three months ended June 30 Six months ended June 30 RESTRUCTURING CHARGES 2024 2023 2024 2023 Workforce reductions $ 42 $ 32 $ 108 $ 52 Plant closures & associated costs and other asset write-downs 5 12 24 37 Acquisition/disposition net charges and other 36 3 38 5 $ 84 $ 46 $ 170 $ 94 Cost of equipment/services $ — $ 3 $ 1 $ 6 Selling, general and administrative expenses 84 43 169 87 Total restructuring charges(a) $ 84 $ 46 $ 170 $ 94 Restructuring charges and other cash expenditures(b) $ 24 $ 97 $ 99 $ 144 (a) In the second quarter of 2024, included income of $81 million, as a result of a change in estimate of the post-employment severance benefit reserve in connection with the separation of GE Vernova. (b) Primarily related to employee severance payments.

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	6 Months Ended
FINANCIAL INSTRUMENTS (Tables)	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Estimated Fair Value of Assets and Liabilities	The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. June 30, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,071 $ 1,977 $ 2,110 $ 2,055 Liabilities Borrowings (Note 10) 19,673 18,949 20,525 20,218 Investment contracts (Note 12) 1,451 1,507 1,535 1,616
Schedule of Fair Value of Derivative Assets	FAIR VALUE OF DERIVATIVES June 30, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 1,287 $ 15 $ 12 $ 1,613 $ 26 $ 22 Non-qualifying currency exchange contracts and other(a) 6,842 208 17 16,277 245 56 Gross derivatives $ 8,129 $ 223 $ 29 $ 17,890 $ 271 $ 78 Netting and credit adjustments $ (13) $ (13) $ (28) $ (26) Net derivatives recognized in statement of financial position $ 210 $ 16 $ 243 $ 53 (a) Gains and (losses) included in our statement of earnings (loss) are $40 million and $46 million for the three months and $62 million and $179 million for the six months ended June 30, 2024 and 2023, respectively, primarily in SG&A, driven by hedges of deferred incentive compensation.
Schedule of Fair Value of Derivative Liabilities	FAIR VALUE OF DERIVATIVES June 30, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 1,287 $ 15 $ 12 $ 1,613 $ 26 $ 22 Non-qualifying currency exchange contracts and other(a) 6,842 208 17 16,277 245 56 Gross derivatives $ 8,129 $ 223 $ 29 $ 17,890 $ 271 $ 78 Netting and credit adjustments $ (13) $ (13) $ (28) $ (26) Net derivatives recognized in statement of financial position $ 210 $ 16 $ 243 $ 53 (a) Gains and (losses) included in our statement of earnings (loss) are $40 million and $46 million for the three months and $62 million and $179 million for the six months ended June 30, 2024 and 2023, respectively, primarily in SG&A, driven by hedges of deferred incentive compensation.
Schedule of Effects of Derivatives on AOCI	Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Amount of Gain (Loss) Reclassified from AOCI into Net Income Three months and six months ended June 30 Three months and six months ended June 30 2024 2023 2024 2023 2024 2023 2024 2023 Cash flow hedges(a) $ (14) $ 19 $ (21) $ 38 $ 5 $ 17 $ 12 $ 18 Net investment hedges(b) 68 (68) 150 (133) — — — — (a) Primarily currency exchange contracts, and recognized in Costs of Equipment or Services Sold in the Statement of Earnings (Loss).

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	6 Months Ended
SEGMENT INFORMATION (Tables)	Jun. 30, 2024
Segment Reporting [Abstract]
Summary of Reportable Segments	SUMMARY OF REPORTABLE SEGMENTS Three months ended June 30 Six months ended June 30 2024 2023 2024 2023 Commercial Engines & Services $ 6,132 $ 5,737 $ 12,228 $ 10,969 Defense & Propulsion Technologies 2,401 2,375 4,713 4,341 Total segment revenues 8,533 8,113 16,941 15,310 Corporate & Other 561 642 1,108 1,281 Total revenues $ 9,094 $ 8,755 $ 18,048 $ 16,591 Commercial Engines & Services $ 1,679 $ 1,389 $ 3,098 $ 2,603 Defense & Propulsion Technologies 344 201 600 402 Total segment profit (loss) 2,023 1,590 3,698 3,006 Corporate & Other (534) (84) (179) 5,429 Interest and other financial charges (248) (249) (511) (497) Non-operating benefit income (cost) 204 249 421 488 Benefit (provision) for income taxes (125) (253) (369) (467) Preferred stock dividends — (58) — (204) Earnings (loss) from continuing operations attributable to common shareholders 1,320 1,195 3,061 7,755 Earnings (loss) from discontinued operations attributable to common shareholders (54) (1,221) (256) (417) Net earnings (loss) attributable to common shareholders $ 1,266 $ (25) $ 2,805 $ 7,338
Schedule of Equipment and Services Revenues	EQUIPMENT & SERVICES REVENUES Three months ended June 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 1,427 $ 4,705 $ 6,132 $ 1,607 $ 4,130 $ 5,737 Defense & Propulsion Technologies 1,071 1,329 2,401 1,137 1,238 2,375 Total segment revenues $ 2,498 $ 6,034 $ 8,533 $ 2,744 $ 5,368 $ 8,113 Six months ended June 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 3,133 $ 9,095 $ 12,228 $ 2,906 $ 8,063 $ 10,969 Defense & Propulsion Technologies 2,080 2,633 4,713 1,994 2,347 4,341 Total segment revenues $ 5,213 $ 11,728 $ 16,941 $ 4,900 $ 10,410 $ 15,310

BUSINESSES HELD FOR SALE AND _3

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Assets Held for Sale Narrative (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2024
Disposed of by sale, not discontinued operations \| Riverstone International Holdings Inc
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from business dispositions	$ 120
Held for sale, not discontinued operation \| Non-core licensing business \| Forecast
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from business dispositions		$ 429

BUSINESSES HELD FOR SALE AND _4

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Assets and Liabilities of Businesses Held for Sale (Details) - Held for sale, not discontinued operation - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Assets
Non-current captive insurance investment securities	$ 0	$ 570
Property, plant and equipment and intangible assets - net	89	17
Valuation allowance on disposal group classified as held for sale	0	(124)
All other assets	49	77
Assets of discontinued operations	137	541
Liabilities
Insurance liabilities and annuity benefits	0	376
Accounts payable and other liabilities	21	1
Borrowings	39	0
Liabilities of discontinued operations	$ 61	$ 378

BUSINESSES HELD FOR SALE AND _5

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Discontinued Operations Narrative (Details) - USD ($) $ in Millions			3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 02, 2024	Jan. 03, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash balance	$ 4,242
Spinoff \| GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operations after disposal, sales			$ 69
Discontinued operations after disposal, cash collected (paid)			477
Spinoff \| GE HealthCare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operations after disposal, cash collected (paid)					$ 157
Ownership interest disposed of		80.10%
Spinoff \| GE Vernova Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash payments associated with transaction	$ 515
Discontinued operations \| Bank BPH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax non-cash charges			0	$ 1,014	0	$ 1,189
Capital contribution, non-cash					0		$ 1,797
Discontinued operations \| Bank BPH \| Bank BPH litigation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Estimated borrower litigation losses			$ 2,474		$ 2,474		$ 2,669

BUSINESSES HELD FOR SALE AND _6

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
RESULTS OF DISCONTINUED OPERATIONS
Earnings (loss) from discontinued operations, net of taxes	$ (54)	$ (1,218)	$ (232)	$ (447)
Discontinued operations
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	8,136	7,244	14,923
Cost of equipment and services sold	0	(6,885)	(6,074)	(12,752)
Other income, costs and expenses	(2)	(2,412)	(1,284)	(3,980)
Earnings (loss) of discontinued operations before income taxes	(2)	(1,161)	(115)	(1,809)
Benefit (provision) for income taxes	(61)	(62)	(129)	1,359
Earnings (loss) of discontinued operations, net of taxes	(63)	(1,222)	(243)	(450)
Gain (loss) on disposal before income taxes	9	4	11	4
Benefit (provision) for income taxes	0	0	0	0
Gain (loss) on disposal, net of taxes	9	4	11	4
Earnings (loss) from discontinued operations, net of taxes	(54)	(1,218)	(232)	(447)
Assets
Cash, cash equivalents and restricted cash	1,398		1,398		$ 3,762
Current receivables	12		12		7,324
Inventories, including deferred inventory costs	0		0		8,245
Goodwill	0		0		4,437
Other intangible assets - net	0		0		1,053
Contract and other deferred assets	0		0		8,959
Property, plant and equipment - net	48		48		5,306
All other assets	332		332		5,750
Deferred income taxes	28		28		3,093
Assets of discontinued operations	1,817		1,817		47,927
Liabilities
Accounts payable	81		81		8,475
Contract liabilities, progress collections & deferred income	0		0		15,255
Long-term borrowings	0		0		294
Non-current compensation and benefits	34		34		3,589
All other liabilities	1,552		1,552		11,600
Liabilities of discontinued operations	1,667		1,667		39,213
Discontinued operations \| GE Vernova
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	8,136	7,244	14,923
Cost of equipment and services sold	0	(6,885)	(6,074)	(12,752)
Other income, costs and expenses	(11)	(1,373)	(1,299)	(2,719)
Earnings (loss) of discontinued operations before income taxes	(11)	(121)	(129)	(548)
Benefit (provision) for income taxes	(58)	(79)	(132)	(137)
Earnings (loss) of discontinued operations, net of taxes	(68)	(200)	(261)	(685)
Gain (loss) on disposal before income taxes	0	0	0	0
Benefit (provision) for income taxes	0	0	0	0
Gain (loss) on disposal, net of taxes	0	0	0	0
Earnings (loss) from discontinued operations, net of taxes	(68)	(200)	(261)	(685)
Assets
Assets of discontinued operations	113		113		46,233
Liabilities
Liabilities of discontinued operations	288		288		$ 38,021
Discontinued operations \| GE HealthCare
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0	0	0
Cost of equipment and services sold	0	0	0	0
Other income, costs and expenses	10	0	11	(20)
Earnings (loss) of discontinued operations before income taxes	10	0	11	(20)
Benefit (provision) for income taxes	(2)	6	(2)	1,485
Earnings (loss) of discontinued operations, net of taxes	8	6	9	1,466
Gain (loss) on disposal before income taxes	0	0	0	0
Benefit (provision) for income taxes	0	0	0	0
Gain (loss) on disposal, net of taxes	0	0	0	0
Earnings (loss) from discontinued operations, net of taxes	8	6	9	1,466
Discontinued operations \| Bank BPH & Other
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0	0	0
Cost of equipment and services sold	0	0	0	0
Other income, costs and expenses	(2)	(1,040)	4	(1,241)
Earnings (loss) of discontinued operations before income taxes	(2)	(1,040)	4	(1,241)
Benefit (provision) for income taxes	(1)	11	5	10
Earnings (loss) of discontinued operations, net of taxes	(3)	(1,029)	9	(1,231)
Gain (loss) on disposal before income taxes	9	4	11	4
Benefit (provision) for income taxes	0	0	0	0
Gain (loss) on disposal, net of taxes	9	4	11	4
Earnings (loss) from discontinued operations, net of taxes	$ 6	$ (1,025)	$ 20	$ (1,227)

BUSINESSES HELD FOR SALE AND _7

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations - Footnote (Details) - Discontinued operations - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Valuation allowance on finance receivables classified as held for sale	$ 1,742	$ 1,963
All other liabilities	1,552	11,600
Assets of discontinued operations	1,817	47,927
Liabilities of discontinued operations	1,667	39,213
GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of discontinued operations	113	46,233
Liabilities of discontinued operations	288	38,021
Bank BPH \| Bank BPH litigation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Valuation allowance on finance receivables classified as held for sale	1,501	1,712
All other liabilities	973	957
Estimated borrower litigation losses	$ 2,474	$ 2,669

INVESTMENT SECURITIES - Narrati

INVESTMENT SECURITIES - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Accrued interest, current	$ 468		$ 468		$ 466
Accrued interest, current, statement of financial position	All other current assets (Note 9)		All other current assets (Note 9)		All other current assets (Note 9)
Debt securities in unrealized loss position, total	$ 21,476		$ 21,476		$ 18,730
Debt securities in unrealized loss position, 12 months or more	16,283		16,283		17,146
Gross unrealized losses, 12 months or more	(2,813)		(2,813)		(2,370)
Gross unrealized losses	(2,946)		(2,946)		(2,406)
Investments without readily determinable fair value	1,141		1,141		974
Fair value adjustments, including impairment	29	$ 26	63	$ 35
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment securities with a fair value	7,088		7,088		6,841
U.S. corporate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	(2,122)		(2,122)		(1,606)
CMBS
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	(138)		(138)
Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	(71)		(71)
Insurance
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments without readily determinable fair value	$ 1,115		$ 1,115		$ 939
GE HealthCare
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, remaining interest (in shares)	30.5		30.5
Equity securities, ownership percentage	6.70%		6.70%

INVESTMENT SECURITIES - Schedul

INVESTMENT SECURITIES - Schedule of Investment Securities (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	$ 0	$ 0
Estimated fair value	3,338	5,706
Gross unrealized gains	719	1,183
Gross unrealized losses	(2,946)	(2,406)
Other equity	198	331
Non-current investment securities, amortized cost	40,356	39,222
Non-current investment securities, estimated fair value	38,129	38,000
U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	27,771	27,495
Gross unrealized gains	618	1,034
Gross unrealized losses	(2,122)	(1,606)
Estimated fair value	26,268	26,923
Non-U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,710	2,529
Gross unrealized gains	23	34
Gross unrealized losses	(270)	(209)
Estimated fair value	2,463	2,353
State and municipal
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,647	2,828
Gross unrealized gains	36	79
Gross unrealized losses	(220)	(185)
Estimated fair value	2,464	2,723
Mortgage and asset-backed
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	5,044	4,827
Gross unrealized gains	40	34
Gross unrealized losses	(220)	(291)
Estimated fair value	4,864	4,571
Government and agencies
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	1,985	1,213
Gross unrealized gains	1	3
Gross unrealized losses	(114)	(116)
Estimated fair value	1,873	1,100
GE HealthCare
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	0	0
Estimated fair value	2,379	4,761
AerCap
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	0	0
Estimated fair value	$ 959	$ 944

INVESTMENT SECURITIES - Realize

INVESTMENT SECURITIES - Realized and Unrealized Gain (Loss) on Securities (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV)	$ (378)	$ 522	$ 62	$ 6,562
Proceeds from debt/equity securities sales and early redemptions	1,083	3,745	4,278	6,754
Gross realized gains on debt securities	9	26	17	38
Gross realized losses on debt securities	$ (28)	$ (25)	$ (38)	$ (46)

INVESTMENT SECURITIES - Contrac

INVESTMENT SECURITIES - Contractual Maturities (Details) $ in Millions	Jun. 30, 2024 USD ($)
Amortized cost
Within one year	$ 1,422
After one year through five years	5,249
After five years through ten years	4,911
After ten years	23,532
Estimated fair value
Within one year	1,417
After one year through five years	5,269
After five years through ten years	4,917
After ten years	$ 21,463

CURRENT AND LONG-TERM RECEIVA_3

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Current Receivables (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
Customer receivables	$ 6,484	$ 6,397
Revenue sharing partners receivables	1,223	1,252
Non-income based tax receivables	117	129
Supplier advances	351	401
Receivables from disposed businesses	217	121
Other sundry receivables	114	534
Allowance for credit losses	(135)	(132)
Total current receivables	8,370	$ 8,703
New provisions	$ 10

CURRENT AND LONG-TERM RECEIVA_4

CURRENT AND LONG-TERM RECEIVABLES - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Receivables [Abstract]
Sale of current customer receivables	$ 240	$ 434

CURRENT AND LONG-TERM RECEIVA_5

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Long-term Receivables (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
Long-term customer receivables	$ 172	$ 163
Supplier advances	30	32
Sundry receivables	114	158
Allowance for credit losses	(3)	(4)
Total long-term receivables	$ 313	$ 349

INVENTORIES, INCLUDING DEFERR_3

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 7,263	$ 6,531
Finished goods	1,277	1,209
Deferred inventory costs	929	544
Inventories, including deferred inventory costs	$ 9,469	$ 8,284

PROPERTY, PLANT AND EQUIPMENT_3

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Original cost	$ 15,439	$ 15,338
Less accumulated depreciation and amortization	(9,430)	(9,252)
Right-of-use operating lease assets	1,086	1,160
Property, plant and equipment – net	$ 7,095	$ 7,246
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment – net	Property, plant and equipment – net

PROPERTY, PLANT AND EQUIPMENT_4

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Operating lease liabilities, current	$ 292		$ 292		$ 308
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	All other current liabilities (Note 14)		All other current liabilities (Note 14)		All other current liabilities (Note 14)
Operating lease liabilities, noncurrent	$ 862		$ 862		$ 931
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	All other liabilities (Note 14)		All other liabilities (Note 14)		All other liabilities (Note 14)
Long-term (fixed) expense	$ 128	$ 124	$ 240	$ 245

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill Balances (Details) $ in Millions	6 Months Ended
	Jun. 30, 2024 USD ($)
Goodwill
Balance at beginning of period	$ 8,948
Goodwill adjustments	(88)
Balance at end of period	8,859
Operating segments \| Commercial Engines & Services
Goodwill
Balance at beginning of period	6,472
Goodwill adjustments	(70)
Balance at end of period	6,402
Operating segments \| Defense & Propulsion Technologies
Goodwill
Balance at beginning of period	2,476
Goodwill adjustments	(19)
Balance at end of period	$ 2,457

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Goodwill [Line Items]
Goodwill	$ 8,859		$ 8,859		$ 8,948
Increase (decrease) in intangible assets			(248)
Amortization of intangible assets	83	$ 96	172	$ 184
Operating segments \| Defense & Propulsion Technologies
Goodwill [Line Items]
Goodwill	2,457		2,457		$ 2,476
Operating segments \| Additive \| Defense & Propulsion Technologies
Goodwill [Line Items]
Goodwill	$ 241		$ 241

CONTRACT AND OTHER DEFERRED A_3

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Capitalized Contract Cost [Line Items]
Contract assets (liabilities) and other deferred assets (income), increase net liability position	$ 474
Increase (decrease) in long-term service agreement liabilities	435
Increase (decrease) in long-term service agreement assets	(261)
Increase (decrease) in equipment and other service agreements	105
Revenue recognized, contract liability	3,537	$ 3,145
Increase in progress collections and deferred income due to timing of revenue recognition	288
Long-term
Capitalized Contract Cost [Line Items]
Increase (decrease) due to billings	(4,181)
Net favorable (unfavorable) change in estimated profitability	(184)
Revenues recognized, contract asset	$ 3,721

CONTRACT AND OTHER DEFERRED A_4

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS - Schedule of Contract Assets, Liabilities and Other Deferred Assets and Income (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Contractors [Abstract]
Long-term service agreements	$ 2,116	$ 2,377
Equipment and other service agreements	603	498
Current contract assets	2,719	2,875
Nonrecurring engineering costs	2,434	2,444
Customer advances and other	2,367	2,342
Contract and other deferred assets	4,801	4,785
Total contract and other deferred assets	7,521	7,660
Long-term service agreement liabilities	8,337	7,902
Current deferred income	335	420
Contract liabilities and current deferred income	8,671	8,322
Non-current deferred income	960	975
Total contract liabilities and deferred income	9,631	9,297
Contract assets (liabilities) and other deferred assets (income)	$ (2,111)	$ (1,637)

ALL OTHER ASSETS (Details)

ALL OTHER ASSETS (Details) - USD ($) $ in Millions	6 Months Ended
ALL OTHER ASSETS (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Increase in other non-current assets	$ 1,710
Increase in insurance cash and cash equivalents	659
Increase in indemnity assets	502
Increase in equity method investments	259
Increase in prepaid taxes and deferred charges	170
Insurance cash and cash equivalents	$ 1,442	$ 784

BORROWINGS (Details)

BORROWINGS (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total short-term borrowings	$ 1,700	$ 1,108
Long-term borrowings and lease obligation	17,973	19,417
Total borrowings	19,673	20,525
Senior notes
Debt Instrument [Line Items]
Long-term borrowings	16,155	17,509
Subordinated notes and other
Debt Instrument [Line Items]
Long-term borrowings	1,359	1,383
Other
Debt Instrument [Line Items]
Long-term borrowings and lease obligation	458	525
Senior notes
Debt Instrument [Line Items]
Current portion of long-term borrowings	1,630	1,044
Subordinated notes and other
Debt Instrument [Line Items]
Current portion of long-term borrowings	71	27
Other short-term borrowings
Debt Instrument [Line Items]
Other short-term borrowings	$ 0	$ 37

ACCOUNTS PAYABLE - Schedule of

ACCOUNTS PAYABLE - Schedule of Accounts Payable and Accruals (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Trade payables	$ 5,604	$ 5,290
Supply chain finance programs	1,496	1,472
Sundry payables	608	754
Accounts Payable and Other Accrued Liabilities, Current	$ 7,707	$ 7,516

ACCOUNTS PAYABLE - Narrative (D

ACCOUNTS PAYABLE - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Payables and Accruals [Abstract]
Supplier finance program, invoices paid	$ 1,799	$ 1,510

INSURANCE LIABILITIES AND ANN_3

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Narrative (Details) $ in Millions	3 Months Ended			6 Months Ended		66 Months Ended
	Jun. 30, 2024 USD ($) loan	Mar. 31, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) loan	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) loan	Dec. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Insurance revenues	$ 871		$ 847	$ 1,750	$ 1,639
Net earnings (loss)	$ 1,268		37	$ 2,833	7,518
Percent of portfolio held in office sector	33.30%			33.30%		33.30%
Gross premium income				$ 409	424
Interest accretion				879	869
Policyholder account balance	$ 1,654		$ 1,884	1,654	1,884	$ 1,654
Policyholder account balance, surrender, withdrawal and benefit payments				215	219
Policyholder account balance, net additions and interest credited				$ 142	$ 134
Policyholder account balance, crediting rate	3%		6%	3%	6%	3%
Capital contributions to insurance subsidiaries		$ 1,820				$ 15,035
Long-term care
Disaggregation of Revenue [Line Items]
Gross premium income				$ 242	$ 246
Interest accretion				637	621
Life
Disaggregation of Revenue [Line Items]
Gross premium income				156	166
Interest accretion				222	229
Run-off Insurance Operations
Disaggregation of Revenue [Line Items]
Insurance revenues	$ 871		$ 847	1,750	1,639
Gross profit (loss)	170		64	370	134
Net earnings (loss)	134		$ 50	292	$ 104
Investment securities	37,739			37,739		37,739	$ 37,592
Limited partnerships	3,741			3,741		3,741	3,300
Run-off Insurance Operations \| CMBS
Disaggregation of Revenue [Line Items]
Debt securities, net	1,900			1,900		1,900	1,947
Debt securities, allowance for credit losses	$ 65			$ 65		$ 65	$ 48
Number of delinquent loans \| loan	3			3		3
Number of nonaccrual loans \| loan	2			2		2
Weighted average loan to value ratio	74%			74%		74%
Debt service coverage ratio	1.5			1.5		1.5

INSURANCE LIABILITIES AND ANN_4

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Schedule of Investment Contracts, Insurance Liabilities and Insurance Annuity Benefits (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	$ 35,376	$ 37,689
Investment contracts	1,451	1,535
Other	388	400
Total	37,215	39,624
Long-term care
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	25,301	26,832	$ 25,888
Investment contracts	0	0
Other	0	0
Total	25,301	26,832
Structured settlement annuities
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	8,700	9,357	9,224
Investment contracts	762	793
Other	0	0
Total	9,463	10,150
Life
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	1,010	1,117	$ 985
Investment contracts	0	0
Other	118	116
Total	1,127	1,233
Other contracts
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	365	382
Investment contracts	689	742
Other	270	285
Total	$ 1,324	$ 1,409

INSURANCE LIABILITIES AND ANN_5

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Changes in Future Policy Benefit Reserves (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Present value of expected future policy benefits
Future policy benefit reserves	$ 35,376		$ 37,689
Long-term care
Present value of expected net premiums
Balance, beginning of year	4,063	$ 4,059
Beginning balance at locked-in discount rate	3,745	3,958
Effect of changes in cash flow assumptions			16	$ 1
Effect of actual variances from expected experience			(26)	31
Adjusted beginning of year balance			3,735	3,991
Interest accrual	101	105
Net premiums collected	(196)	(201)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	3,640	3,895
Effect of changes in discount rate assumptions	164	239
Balance, end of year	3,803	4,134
Present value of expected future policy benefits
Balance, beginning of year	30,895	28,316
Beginning balance at locked-in discount rate	27,185	27,135	27,144	27,026
Effect of changes in cash flow assumptions			(10)	(14)
Effect of actual variances from expected experience			7	26
Adjusted beginning of year balance			27,141	27,038
Interest accrual	738	727
Benefit payments	(693)	(630)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	27,185	27,135
Effect of changes in discount rate assumptions	1,920	2,887
Balance, end of year	29,105	30,022
Future policy benefit reserves	25,301	25,888	26,832
Less: Reinsurance recoverables, net of allowance for credit losses	(155)	(186)
Net future policy benefit reserves, after reinsurance recoverables	25,146	25,702
Structured settlement annuities
Present value of expected net premiums
Balance, beginning of year	0	0
Beginning balance at locked-in discount rate	0	0
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			0	0
Adjusted beginning of year balance			0	0
Interest accrual	0	0
Net premiums collected	0	0
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	0	0
Effect of changes in discount rate assumptions	0	0
Balance, end of year	0	0
Present value of expected future policy benefits
Balance, beginning of year	9,357	8,860
Beginning balance at locked-in discount rate	8,429	8,691	8,561	8,790
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(25)	10
Adjusted beginning of year balance			8,536	8,800
Interest accrual	222	229
Benefit payments	(328)	(338)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	8,429	8,691
Effect of changes in discount rate assumptions	271	533
Balance, end of year	8,700	9,224
Future policy benefit reserves	8,700	9,224	9,357
Less: Reinsurance recoverables, net of allowance for credit losses	0	0
Net future policy benefit reserves, after reinsurance recoverables	8,700	9,224
Life
Present value of expected net premiums
Balance, beginning of year	4,803	4,828
Beginning balance at locked-in discount rate	4,773	5,210
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(34)	(87)
Adjusted beginning of year balance			4,739	5,122
Interest accrual	90	100
Net premiums collected	(140)	(150)
Effect of foreign currency	(91)	86
Ending balance at locked-in discount rate	4,597	5,159
Effect of changes in discount rate assumptions	(183)	(162)
Balance, end of year	4,415	4,997
Present value of expected future policy benefits
Balance, beginning of year	5,921	5,868
Beginning balance at locked-in discount rate	5,591	6,126	5,847	6,247
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(51)	(44)
Adjusted beginning of year balance			5,796	$ 6,203
Interest accrual	110	119
Benefit payments	(219)	(287)
Effect of foreign currency	(96)	91
Ending balance at locked-in discount rate	5,591	6,126
Effect of changes in discount rate assumptions	(166)	(144)
Balance, end of year	5,424	5,983
Future policy benefit reserves	1,010	985	$ 1,117
Less: Reinsurance recoverables, net of allowance for credit losses	(31)	(34)
Net future policy benefit reserves, after reinsurance recoverables	$ 979	$ 952

INSURANCE LIABILITIES AND ANN_6

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Amount of Undiscounted and Discounted (Details) - USD ($) $ in Millions	Jun. 30, 2024	Jun. 30, 2023
Long-term care
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Undiscounted, Gross premiums	$ 7,244	$ 7,807
Undiscounted, Benefit payments	62,387	64,585
Discounted, Gross premiums	4,665	4,995
Discounted, Benefit payments	29,105	30,022
Structured settlement annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Undiscounted, Benefit payments	18,937	19,608
Discounted, Benefit payments	8,700	9,224
Life
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Undiscounted, Gross premiums	11,886	13,620
Undiscounted, Benefit payments	10,730	11,850
Discounted, Gross premiums	5,323	6,125
Discounted, Benefit payments	$ 5,424	$ 5,983

INSURANCE LIABILITIES AND ANN_7

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Weighted-Average Durations and Interest Rates (Details)	Jun. 30, 2024	Jun. 30, 2023
Long-term care
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	12 years 1 month 6 days	13 years 1 month 6 days
Interest Accretion Rate	5.60%	5.50%
Current Discount Rate	5.40%	5.10%
Structured settlement annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	10 years 8 months 12 days	11 years 1 month 6 days
Interest Accretion Rate	5.40%	5.40%
Current Discount Rate	5.40%	5.10%
Life
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	5 years 4 months 24 days	5 years 3 months 18 days
Interest Accretion Rate	5.20%	5.10%
Current Discount Rate	5.10%	5%

POSTRETIREMENT BENEFIT PLANS -

POSTRETIREMENT BENEFIT PLANS - Narrative (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024 USD ($) category	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) category	Jun. 30, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of categories \| category	3		3
Defined contribution plan costs	$ 74	$ 103	$ 163	$ 180
Deferred compensation expense	12	15	21	35
Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan costs	74	63	128	110
Deferred compensation expense	12	12	14	29
Principal retiree benefit plans
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	(21)	(36)	(57)	(72)
Principal retiree benefit plans \| Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	(21)	(22)	(43)	(44)
Other pension plans
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	1	(30)	(12)	(59)
Other pension plans \| Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	$ 1	$ (10)	$ 0	$ (20)

POSTRETIREMENT BENEFIT PLANS _2

POSTRETIREMENT BENEFIT PLANS - Effect on Operations of Pension Plans (Details) - Principal pension plans - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Defined Benefit Plan Disclosure [Line Items]
Service cost for benefits earned	$ 17	$ 24	$ 37	$ 45
Prior service cost amortization	1	0	4	0
Expected return on plan assets	(390)	(594)	(968)	(1,188)
Interest cost on benefit obligations	315	472	768	946
Net actuarial gain amortization	(103)	(187)	(257)	(359)
Net periodic expense (income)	(160)	(285)	(416)	(556)
Discontinued operations
Defined Benefit Plan Disclosure [Line Items]
Net periodic expense (income)	0	(96)	(88)	(188)
Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Net periodic expense (income)	$ (160)	$ (189)	$ (328)	$ (368)

SALES DISCOUNTS AND ALLOWANCE_2

SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Other Liabilities Disclosure [Abstract]
Increase (decrease) in sales discount and allowances	$ (102)	$ 32
Increase (decrease) in other current liabilities	(355)
Increase (decrease) in employee compensation and benefit liabilities	(758)
Increase (decrease) in dividends payable	217
Increase (decrease) in taxes payable	87
Increase (decrease) in other noncurrent liabilities	827
Increase (decrease) in uncertain and other income taxes and related liabilities	585
Increase (decrease) in environmental, health and safety liabilities, noncurrent	142
Increase (decrease) in indemnity liabilities	$ 185

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details)	6 Months Ended
INCOME TAXES - Narrative (Details)	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	10.70%	5.50%

INCOME TAXES - Deferred Income

INCOME TAXES - Deferred Income Taxes (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Total assets	$ 7,702	$ 7,891
Total liabilities	(364)	(389)
Net deferred income tax asset (liability)	$ 7,338	$ 7,502

SHAREHOLDERS' EQUITY - Schedule

SHAREHOLDERS' EQUITY - Schedule of Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended		3 Months Ended			6 Months Ended
	Jun. 30, 2024	Apr. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance						$ 28,605
Ending balance	$ 18,843		$ 18,843	$ 32,393		$ 18,843	$ 32,393
Dividends declared per common share (in dollars per share)	$ 0.28	$ 0.28	$ 0.56	$ 0.08		$ 0.56	$ 0.16
GE Vernova
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes			$ 1,590
GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes					$ 195
Accumulated other comprehensive income (loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance		$ (5,603)	(5,603)	$ (3,289)	(2,272)	$ (6,150)	$ (2,272)
Ending balance	$ (4,035)		(4,035)	(3,573)	(3,289)	(4,035)	(3,573)
Currency translation adjustments, including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance		(3,658)	(3,658)	(3,505)	(5,893)	(3,623)	(5,893)
AOCI before reclass, net of taxes			29	67		(6)	220
Reclass from AOCI, net of taxes			2,094	27		2,094	2,262
Other comprehensive income (loss)			2,123	95		2,087	2,481
Ending balance					(3,505)
AOCI before reclasses, taxes			(39)	(13)		(13)	(18)
Reclass from AOCI, taxes			103	0		103	(626)
Currency translation adjustments, including noncontrolling interests \| GE Vernova
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes			2,174
Currency translation adjustments, including noncontrolling interests \| GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes					2,234
Currency translation adjustments, attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)			(22)	(2)		(22)	(3)
Currency translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)			2,144	96		2,109	2,484
Ending balance	(1,514)		(1,514)	(3,409)		(1,514)	(3,409)
Benefit plans, including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance		1,586	1,586	4,214	6,531	1,786	6,531
AOCI before reclass, net of taxes			(54)	41		(83)	(43)
Reclass from AOCI, net of taxes			(736)	(214)		(904)	(2,449)
Other comprehensive income (loss)			(790)	(173)		(987)	(2,492)
Ending balance					4,214
AOCI before reclasses, taxes			(12)	12		(4)	(1)
Reclass from AOCI, taxes			(156)	(63)		(208)	(657)
Benefit plans, including noncontrolling interests \| GE Vernova
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes			(584)
Benefit plans, including noncontrolling interests \| GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes					(2,030)
Benefit plans, attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)			(9)	0		(7)	(2)
Benefit plans AOCI
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)			(780)	(173)		(980)	(2,490)
Ending balance	806		806	4,041		806	4,041
Investment securities and cash flow hedges, including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance		(1,412)	(1,412)	(1,222)	(1,927)	(959)	(1,927)
AOCI before reclass, net of taxes			(341)	(446)		(806)	272
Reclass from AOCI, net of taxes			37	(28)		48	(41)
Other comprehensive income (loss)			(304)	(474)		(758)	231
Ending balance					(1,222)
AOCI before reclasses, taxes			(92)	(127)		(208)	61
Reclass from AOCI, taxes			13	(3)		12	(3)
Investment securities and cash flow hedges, attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)			12	0		12	0
Investment securities and cash flow hedges AOCI
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)			(314)	(474)		(768)	231
Ending balance	(1,727)		(1,727)	(1,696)		(1,727)	(1,696)
Long-duration insurance contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance		$ (2,119)	(2,119)	(2,776)	(983)	(3,354)	(983)
AOCI before reclass, net of taxes			518	267		1,753	(1,527)
Other comprehensive income (loss)			518	267		1,753	(1,527)
Ending balance	$ (1,601)		(1,601)	(2,510)	$ (2,776)	(1,601)	(2,510)
AOCI before reclasses, taxes			$ 138	$ 71		$ 466	$ (406)

SHAREHOLDERS' EQUITY - Narrativ

SHAREHOLDERS' EQUITY - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Mar. 31, 2023	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares outstanding					2,795,444
Common stock, shares outstanding	1,084,311,016		1,084,311,016	1,088,415,995
Stock repurchased (in shares)	13,900,000		15,000,000
Stock repurchased	$ 2,289		$ 2,434
Preferred stock
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock repurchased		$ 3,000

EARNINGS PER SHARE INFORMATIO_2

EARNINGS PER SHARE INFORMATION (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Diluted
Earnings (loss) from continuing operations	$ 1,320	$ 1,254	$ 3,061	$ 7,951
Preferred stock dividends and other	0	(58)	0	(204)
Earnings (loss) from continuing operations attributable to common shareholders	1,320	1,195	3,061	7,747
Earnings (loss) from discontinued operations	(54)	(1,220)	(256)	(417)
Net earnings (loss) attributable to common shareholders	$ 1,266	$ (25)	$ 2,805	$ 7,330
Total average equivalent shares (in shares)	1,089	1,089	1,089	1,089
Employee compensation-related shares (including stock options) (in shares)	11	10	11	9
Total average equivalent shares (in shares)	1,100	1,098	1,100	1,097
Earnings (loss) per share from continuing operations (in dollars per share)	$ 1.20	$ 1.09	$ 2.78	$ 7.06
Earnings (loss) per share from discontinued operations (in dollars per share)	(0.05)	(1.11)	(0.23)	(0.38)
Net earnings (loss) per share (in dollars per share)	$ 1.15	$ (0.02)	$ 2.55	$ 6.68
Potentially dilutive securities (in shares)	6	28	9	33
Basic
Earnings (loss) from continuing operations	$ 1,320	$ 1,254	$ 3,061	$ 7,958
Preferred stock dividends and other	0	(58)	0	(204)
Earnings (loss) from continuing operations attributable to common shareholders	1,320	1,195	3,061	7,754
Earnings (loss) from discontinued operations	(54)	(1,220)	(256)	(417)
Net earnings (loss) attributable to common shareholders	$ 1,266	$ (25)	$ 2,805	$ 7,337
Earnings (loss) per share from continuing operations (in dollars per share)	$ 1.21	$ 1.10	$ 2.81	$ 7.12
Earnings (loss) per share from discontinued operations (in dollars per share)	(0.05)	(1.12)	(0.23)	(0.38)
Net earnings (loss) per share (in dollars per share)	$ 1.16	$ (0.02)	$ 2.58	$ 6.74
Preferred share redemption
Preferred share redemption, excise tax		$ (30)		$ (30)

OTHER INCOME (LOSS) - Schedule

OTHER INCOME (LOSS) - Schedule of Other Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)			$ 314	$ 6,286
Other net interest and investment income (loss)	$ 200	$ 128	429	296
Licensing and royalty income	51	29	107	54
Other items	46	(39)	95	(72)
Total other income (loss)	(63)	496	944	$ 6,600
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]				Total other income (loss)
Other (income) loss
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity method income	34	20	79	$ 57
Retained and sold ownership interests
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	(394)	358	234	6,266
GE HealthCare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	(397)	(214)	219	5,879
AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	3	572	15	378
Baker Hughes
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	$ 0	$ 0	$ 0	$ 10

OTHER INCOME (LOSS) - Narrative

OTHER INCOME (LOSS) - Narrative (Details) - GE HealthCare shares in Millions, $ in Millions	6 Months Ended
	Jun. 30, 2024 USD ($) shares
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity securities, remaining interest (in shares)	30.5
Equity securities, ownership percentage	6.70%
Dispositions of retained ownership interests, proceeds \| $	$ 2,602
Dispositions of retained ownership interests, shares sold (in shares)	31.1

RESTRUCTURING CHARGES AND SEP_3

RESTRUCTURING CHARGES AND SEPARATION COSTS - Schedule of Restructuring and Other Charges (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Restructuring Cost and Reserve [Line Items]
Total restructuring charges (income)	$ 84	$ 46	$ 170	$ 94
Restructuring charges and other cash expenditures	24	97	99	144
Cost of sales
Restructuring Cost and Reserve [Line Items]
Total restructuring charges (income)	0	3	1	6
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total restructuring charges (income)	84	43	169	87
Workforce reductions
Restructuring Cost and Reserve [Line Items]
Total restructuring charges (income)	42	32	108	52
Workforce reductions \| GE Vernova
Restructuring Cost and Reserve [Line Items]
Total restructuring charges (income)	(81)
Plant closures & associated costs and other asset write-downs
Restructuring Cost and Reserve [Line Items]
Total restructuring charges (income)	5	12	24	37
Acquisition/disposition net charges and other
Restructuring Cost and Reserve [Line Items]
Total restructuring charges (income)	$ 36	$ 3	$ 38	$ 5

RESTRUCTURING CHARGES AND SEP_4

RESTRUCTURING CHARGES AND SEPARATION COSTS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring liability	$ 292		$ 292		$ 311
Separation costs (income)	75	$ 163	334	$ 327
Separation costs
Restructuring Cost and Reserve [Line Items]
Separation costs (income)	75	163	334	327
Payments for restructuring costs	407	319	572	489
Restructuring, incurred net tax expense (benefit)	(216)	(14)	(251)	3
Separation costs \| Discontinued operations \| GE HealthCare
Restructuring Cost and Reserve [Line Items]
Separation costs (income)	(10)	1	(10)	21
Payments for restructuring costs	0	55	9	140
Restructuring, incurred net tax expense (benefit)	2	0	2	(4)
Separation costs \| Discontinued operations \| GE Vernova
Restructuring Cost and Reserve [Line Items]
Separation costs (income)	1	64	97	104
Payments for restructuring costs	38	52	121	86
Restructuring, incurred net tax expense (benefit)	$ 0	$ (20)	$ (20)	$ 18

FINANCIAL INSTRUMENTS - Assets

FINANCIAL INSTRUMENTS - Assets and Liabilities Not Carried at Fair Value (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Liabilities
Investment contracts	$ 1,451	$ 1,535
Carrying amount (net)
Assets
Loans and other receivables	2,071	2,110
Liabilities
Borrowings	19,673	20,525
Investment contracts	1,451	1,535
Estimated fair value
Assets
Loans and other receivables	1,977	2,055
Liabilities
Borrowings	18,949	20,218
Investment contracts	$ 1,507	$ 1,616

FINANCIAL INSTRUMENTS - Fair Va

FINANCIAL INSTRUMENTS - Fair Value of Derivatives (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Gross Notional	$ 8,129	$ 17,890
All other current assets
Derivative asset, statement of financial position	All other current assets (Note 9)	All other current assets (Note 9)
Gross derivatives	$ 223	$ 271
Netting and credit adjustments	(13)	(28)
Net derivatives in statement of financial position	$ 210	$ 243
All other current liabilities
Derivative liability, statement of financial position	All other current liabilities (Note 14)	All other current liabilities (Note 14)
Gross derivatives	$ 29	$ 78
Netting and credit adjustments	(13)	(26)
Net derivatives recognized in statement of financial position	16	53
Qualifying currency exchange contracts
Derivative [Line Items]
Gross Notional	1,287	1,613
All other current assets
Gross derivatives	15	26
All other current liabilities
Gross derivatives	12	22
Non-qualifying currency exchange contracts and other
Derivative [Line Items]
Gross Notional	6,842	16,277
All other current assets
Gross derivatives	208	245
All other current liabilities
Gross derivatives	$ 17	$ 56

FINANCIAL INSTRUMENTS - Fair _2

FINANCIAL INSTRUMENTS - Fair Value of Derivatives, Footnote (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Non-qualifying currency exchange contracts and other
Derivative [Line Items]
Gain (loss) on derivatives	$ 40	$ 46	$ 62	$ 179

FINANCIAL INSTRUMENTS - Fair _3

FINANCIAL INSTRUMENTS - Fair Value Hedges, Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Cumulative gain of fair value hedging adjustments	$ 1,101	$ 1,162
Cumulative gain of fair value hedging on discontinued hedging relationships	1,101	1,162
Hedged liability	$ 8,551	$ 9,253
Hedged Liability, Statement of Financial Position [Extensible Enumeration]	Long-term borrowings (Note 10)	Long-term borrowings (Note 10)

FINANCIAL INSTRUMENTS - Cash Fl

FINANCIAL INSTRUMENTS - Cash Flow Hedges and Net Investment (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gain (loss) recognized in OCI, cash flow hedges	$ (14)	$ 19	$ (21)	$ 38
Gain (loss) recognized in OCI, net investment hedges	68	(68)	150	(133)
Reclassified from AOCI into net income, cash flow hedges	5	17	12	18
Reclassified from AOCI into net income, investment hedges	$ 0	$ 0	$ 0	$ 0

FINANCIAL INSTRUMENTS - Cash _2

FINANCIAL INSTRUMENTS - Cash Flow Hedges and Net Investment, Footnote (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Foreign currency debt
Derivative [Line Items]
Carrying value designated as net investment hedges	$ 4,588	$ 4,726

FINANCIAL INSTRUMENTS - Counter

FINANCIAL INSTRUMENTS - Counterparty Credit Risk, Narrative (Details) - Counterparty credit risk - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Exposure to counterparties (including accrued interest)	$ 210	$ 241
Net amount	$ 16	$ 53

VARIABLE INTEREST ENTITIES (Det

VARIABLE INTEREST ENTITIES (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Variable Interest Entity [Line Items]
Assets	$ 123,190	$ 173,300
Liabilities	104,347	144,695
Consolidated VIE
Variable Interest Entity [Line Items]
Assets	129	115
Liabilities	121	140
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Assets	7,260	6,577
Unconsolidated VIEs \| U.S. Tax Equity Investments
Variable Interest Entity [Line Items]
Assets	1,198	1,205
Unconsolidated VIEs \| Insurance
Variable Interest Entity [Line Items]
Assets	$ 5,828	$ 5,145

COMMITMENTS, GUARANTEES, PROD_2

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Commitments (Details) $ in Millions	Jun. 30, 2024 USD ($)
Investment commitments
Long-term Purchase Commitment [Line Items]
Commitments	$ 3,930
Run-off Insurance Operations
Long-term Purchase Commitment [Line Items]
Commitments	3,774
Run-off insurance operations, unconsolidated VIE investment commitment
Long-term Purchase Commitment [Line Items]
Commitments	3,671
Unfunded lending commitments
Long-term Purchase Commitment [Line Items]
Commitments	656
Financial assistance
Long-term Purchase Commitment [Line Items]
Commitments	$ 2,696

COMMITMENTS, GUARANTEES, PROD_3

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Guarantees (Details) $ in Millions	Jun. 30, 2024 USD ($)
Credit support agreement \| Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	$ 57
Guarantee obligations, liability	7
Credit support agreement \| GE Vernova \| Continuing operations
Guarantor Obligations [Line Items]
Guarantee obligations, reserve	169
Financial guarantee \| GE Vernova \| Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	1,426
Indemnification agreement, SDA, TSA and TMA \| GE Vernova \| Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	168
Guarantee obligations, reserve	122
Indemnification agreement, SDA, TSA and TMA \| GE Vernova \| Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	93
Indemnification agreement, TMA \| GE HealthCare \| Continuing operations
Guarantor Obligations [Line Items]
Guarantee obligations, liability	32
Other indemnification agreements \| Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	148
Guarantee obligations, liability	62
Other indemnification agreements \| Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	510
Guarantee obligations, reserve	63
Performance obligation \| GE Vernova \| Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	1,416
Indemnification agreement, TSA and TMA \| GE HealthCare \| Discontinued operations
Guarantor Obligations [Line Items]
Guarantee obligations, liability	$ 64

COMMITMENTS, GUARANTEES, PROD_4

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Product Warranties (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Liability for product warranties	$ 635	$ 639

COMMITMENTS, GUARANTEES, PROD_5

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Bank BPH (Details) - Bank BPH - Bank BPH litigation - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Litigation settlement expense	$ 1,014
Estimate loss		$ 2,474	$ 2,669

COMMITMENTS, GUARANTEES, PROD_6

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Environmental, Health and Safety Matters (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Total reserves related to environmental remediation and worker exposure claims	$ 1,897	$ 1,819

SEGMENT INFORMATION - Narrative

SEGMENT INFORMATION - Narrative (Details) $ in Millions	6 Months Ended
SEGMENT INFORMATION - Narrative (Details) $ in Millions	Jun. 30, 2024 USD ($) segment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Number of reportable segments \| segment	2
Number of operating segments \| segment	3
Performance obligations expected to be satisfied	$ 159,765
Equipment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 19,191
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 \| Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	37%
Performance obligations expected to be satisfied, expected timing	1 year
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 \| Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	54%
Performance obligations expected to be satisfied, expected timing	2 years
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 \| Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	74%
Performance obligations expected to be satisfied, expected timing	5 years
Services
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 140,574
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 \| Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	11%
Performance obligations expected to be satisfied, expected timing	1 year
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 \| Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	42%
Performance obligations expected to be satisfied, expected timing	5 years
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 \| Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	69%
Performance obligations expected to be satisfied, expected timing	10 years
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 \| Performance obligation satisfaction, period four
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	85%
Performance obligations expected to be satisfied, expected timing	15 years

SEGMENT INFORMATION - Summary o

SEGMENT INFORMATION - Summary of Reportable Segments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	$ 9,094	$ 8,755	$ 18,048	$ 16,591
Interest and other financial charges	(248)	(249)	(511)	(497)
Non-operating benefit income (cost)	204	249	421	488
Benefit (provision) for income taxes	(125)	(253)	(369)	(467)
Earnings (loss) from continuing operations attributable to common shareholders	1,320	1,195	3,061	7,755
Earnings (loss) from discontinued operations attributable to common shareholders	(54)	(1,221)	(256)	(417)
Net earnings (loss) attributable to common shareholders	1,266	(25)	2,805	7,338
Operating segments
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	8,533	8,113	16,941	15,310
Gross profit (loss)	2,023	1,590	3,698	3,006
Operating segments \| Commercial Engines & Services
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	6,132	5,737	12,228	10,969
Gross profit (loss)	1,679	1,389	3,098	2,603
Operating segments \| Defense & Propulsion Technologies
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	2,401	2,375	4,713	4,341
Gross profit (loss)	344	201	600	402
Corporate & Other
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	561	642	1,108	1,281
Gross profit (loss)	(534)	(84)	(179)	5,429
Segment reconciling items
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Interest and other financial charges	(248)	(249)	(511)	(497)
Non-operating benefit income (cost)	204	249	421	488
Benefit (provision) for income taxes	(125)	(253)	(369)	(467)
Preferred stock dividends	$ 0	$ (58)	$ 0	$ (204)

SEGMENT INFORMATION - Schedule

SEGMENT INFORMATION - Schedule of Equipment and Services Revenues (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Total revenues	$ 9,094	$ 8,755	$ 18,048	$ 16,591
Operating segments
Disaggregation of Revenue [Line Items]
Total revenues	8,533	8,113	16,941	15,310
Operating segments \| Commercial Engines & Services
Disaggregation of Revenue [Line Items]
Total revenues	6,132	5,737	12,228	10,969
Operating segments \| Defense & Propulsion Technologies
Disaggregation of Revenue [Line Items]
Total revenues	2,401	2,375	4,713	4,341
Operating segments \| Equipment
Disaggregation of Revenue [Line Items]
Total revenues	2,498	2,744	5,213	4,900
Operating segments \| Equipment \| Commercial Engines & Services
Disaggregation of Revenue [Line Items]
Total revenues	1,427	1,607	3,133	2,906
Operating segments \| Equipment \| Defense & Propulsion Technologies
Disaggregation of Revenue [Line Items]
Total revenues	1,071	1,137	2,080	1,994
Operating segments \| Services
Disaggregation of Revenue [Line Items]
Total revenues	6,034	5,368	11,728	10,410
Operating segments \| Services \| Commercial Engines & Services
Disaggregation of Revenue [Line Items]
Total revenues	4,705	4,130	9,095	8,063
Operating segments \| Services \| Defense & Propulsion Technologies
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,329	$ 1,238	$ 2,633	$ 2,347